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INTRODUCTION 
                                     Siddha –The science of Holistic Health 
                  The word  “siddha” comes from the word  “siddhi” which means “an 
object to be attained” or “perfection” or “heavenly bliss”.(1) Siddhi generally refers to 
Ashtama siddhi i.e, the eight great super natural powers .Those who attained or 
achieved the above said powers are known as Siddhars.                                                                     
                   Science of Siddha states that the 5 elements of Nature viz., earth, water, 
heat, air and space(panchapoodham) were the fundamentals of all the corporeal things 
in the world. It also states that there exists a close relationship between the external 
world and the internal system of human. To be precise,“Structure of the Human 
body is a miniature world by itself”(2). 
                   According to panchapoodha pancheekaranam theory, each of these five 
elements said to posses two properties viz. Subtle and gross. Thus ,This theory 
proposes that 96 basic factors exist, which is the basic concept underlying this holistic 
medical science. The human body formed by these 96 basic factors . This 96 factor 
include physical, physiological, psychological, intellectual aspect of every human. 
The five primordial elements manifest themselves as a human through these 96 basic 
factor
(3)
.  
                    Man is said to be Microcosm(Pindam) and the world the 
Macrocosm(Andam)  i.e., there is nothing in the Macrocosm of nature that is not 
contained in man. Disease, according to modern science is only a departure from a 
state of health and more frequently a kind of disturbance of the healthiness of the 
body to which any particular case of sickness is assigned.According to Siddhars 
Philosophy diseases in man do not originate in himself, but from the influences which 
act upon him.As already stated, man is compared to the world because the elements 
that exist in the world exist in man as well; and therefore any change in the 
elementary condition of the external world has its corresponding change in the human 
organism.There is the feeling of oneness between the external and the internal world 
of man; and it is upon this oneness that the doctrine of Humoral Pathology i.e., the 
theory of Tridosha is based. 
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                                                  -குறள் 
                  The siddha medicine also recognises the role of three Humors (Vatham, 
Pitham and Kapham).These humors remain in a balanced state in normal healthy 
person and disturbance in their equilibrium leads to ill health.
(4) 
                  The characteristic of the three humors in the constitution of human beings 
is either hereditary or atavic. In scientific parlance, Vatham comprehends all the 
phenomena which come under the functions of the central and the sympathetic 
nervous system; Pitham, the functions of thermogenesis or heat-production, 
metabolisation within its limits, the process of digestion, coloration of blood, 
excretion and secretion etc., and Kapham, the regulation of the heat and the formation 
of the various preservative glands.When deranged, they bring about diseases peculiar 
to their influence ; when in equilibrium, freedom from disease; and when one or the 
other of the humours combine in such  a way as to get derangedby aggravation, 
diminution etc., disease  may result.In Siddha diagnosis is based on three humors .
5,6,7)    
                    Thirumoolar is one of the Siddhar. In his famous treatise called 
Thirumanthiram, he define medicine is one that give physiological effects, 
psychological effects, ensures prevention of diseases and ultimately grants 
Immortality. The treatment is mainly directed towards restoration of equilibrium of 
the three Humors .                                  
                      The term “infertility” came from Latin word infertilis, which means 
“not fertile”(8) 
                       Infertility is “a disease of the reproductive system defined by the failure 
to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual 
intercourse.  Infertility, as well as being a medical condition, has a social dimension; it 
is a poorly-controlled, chronic stressor with severe long-lasting negative social and 
psychological consequences.
(9)(10)(11) 
                  In Siddha medicine, infertility in male is called as Aan maladu, 
Veeriyamantham, Anmai kuraipadu. Siddhar Yugimuni in his medical literature 
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“Yugimuni Sigicha Saaram” has described the male infertility due to problems in 
seminal fluid (Vindhu).  
                  According to WHO in word wide 60 – 80 million couples are infertile and, 
in India 10 – 15 % of couples were infertile.12) 1 in 6 couples are infertile and they 
have negative emotional responses such as stress, anxiety and depression. 
The prevalence of infertility in the general population is 15%–20%. Of this, 
the male factor is responsible for 20%–40%. In Indian couples seeking treatment, the 
male  factor is the cause in approximately 23%.
(13) 
              In men, oligozoospermia, asthenozoospermia, teratozoospermia and 
azoospermia are the main causes of infertility, and these account for 20%–25% of 
cases. 
                  Infertility is stressful life event and depressive symptoms are normal 
responses to the life crisis of the infertile couples. Now a days smoking, alcoholism,  
poor nutrition, pesticides level in food, overweight, stress are increasing, which are 
responsible for fertility problems and it ultimately leads to reduction in Birth Rate of 
our country. Reduction in Birth Rate along with already increasing life expectancy 
leads to increase in old age population which makes our country much older. As 
children are the future of our country, it is important to reduce infertility. There are 
many medicines available in Siddha system to treat male infertility. From those, the 
author has selected VEERIYA VIRUTHI CHOORANAM to study its safety and 
efficacy and hopes it will give fruitful results.                     
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AIM & OBJECTIVE 
         AIM: 
                    To study the safety & efficacy of Siddha medicine VEERIYA VIRUTHI    
CHOORANAM in Aan maladu (Male infertility) 
         OBJECTIVE: 
 To evaluate the therapeutic efficacy of VEERIYA VIRUTHI CHOORANAM in 
Aan maladu(Male infertility) to increase the sperm concentration, viscosity of 
semen and to reduce premature ejaculation, nocturnal emission in Aan Maladu. 
 To evaluate the safety profile of the trial drug VEERIYA VIRUTHI 
CHOORANAM. 
 To collect the authorized measures and review the ideas of Aan maladu in 
Siddha and modern literatures. 
 To have an idea about the relation of the disease with age, habits, occupation, 
economic states, family history and climatic conditions. 
 To expose the efficacy of siddhars diagnostic principles such as mukkutram, 
envagai thervugal, eazhu udalthadhukkal, neerkuri and neikkuri. 
 To evaluate, 
 Bio- chemical analysis 
 Physico-Chemical analysis 
 Toxicity study [acute & sub-acute] 
 Pharmacological action 
 Bio –statistical analysis 
 To have detailed clinical investigations. 
 To handle the modern parameters to confirm the diagnosis and prognosis of the 
study. 
 To have a clinical trial on the disease “AAN MALADU” with the Siddha herbal 
formulation of “VEERIYA VIRUTHI CHOORANAM”. 
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AAN MALADU GUNAM: 
According to “ yugi” and the text “arivaiyar sinthamani” 
 Lack of sweetness in semen 
 Buoyancy on water 
 Absence of virility 
 Frothy maturation 
The above told character of semen mainly contributes infertile man. 
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 ACCORDING TO T.V.SAMBASIVAM PILLAI: 
                According to T.V.Sambasivam pillai dictionary, The semen in such cause 
will be devoid of sweetness and life and float on the surface of water. The urine also 
will be frothy. Such man is incapable to impregnate women
(18) 
FORMATION OF FOETUS COMBINES WITH PANICHABOOTHAM:  
 
                   The ovum consists of the element earth, whereas the sperm consists of fire 
and air, the uterine wall nourishes it has water and uterine cavity is one of the element 
of space. Therefore in the formation of fetus all the five elements combine and create 
it. 
THE ROLE OF VAAYUS IN FERTILIZATION: 
Abanan stays outside the zygote and protect it. The pranan goes along with 
spermatozoa and bisects the size of the zygote 
             According to siddha literature & siddhars view, vindhu or sukkilam(semen) is 
an important which is compared to shiva. Vindhu anotherwise known as “sukkilam” is 
the final and important constituent of 7 thathus, which giving birth to embryo.  
             Although all siddhars spoken about vindhu , some of them only briefly 
explained the formation, importance,embryo formation etc. For examble, the famous 
saint THIRUMOOLAR briefly explained the formation of vindhu(semen) , 
physiological importance,disadvantage of masturbation, timing for coitus, state of 
orgasm, embryo formation,determination of foetel sex by male partner,etc in 
Thirumandhiram. Some of the literature views from above told books and some other 
books are given below. 
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FORMATION OF VINDHU(SEMEN): 
Tpe;J ,ay; : 
         ,ur Kjyhd Vo;jhJ %d;wpd; 
         chpa jpdj;jpd; xUGw;gdp Nghy; 
         mhpaJsp Tpe;JthF Nko; %d;wpd; 
         kUtpa Tpe;J tsUk; fhaj;jpNy 
                             
Although 7 thathus noursing our body after getting absorbed from GI Tract, 
3 are the major things that is saram(chyme), raktham (blood)& vinthu (semen). The 
semen seems to be a waterglobules at the hit of grass. The sperm need 21 days for its 
full growth in our body. 
FORMATION OF VINDHU(SEMEN): 
tpe;Jw;gdk; (tpe;Jtpd; Njhw;wk;) 
     rfj;jpd; Njhw;wj;jpw;F %ykhd Rj;jk;  Kjyhd khiaapdpd;W  
tphpAk; tifAk; tpz;lj;jpy; tpe;J tpdpd;W Gzh;r;rpahfpa  fhhpaj;jhd; fU 
cUf;nfhs;SkhW  ahz;L mz;lk; gpz;lk; ,tw;iw ,izj;Nj $Wtuhjypd; 
<z;Lk; rpy ke;jpuq;fshd mz;l epiyf;F  mbahd gu mgu tpe;Jtpd;  
ntspg; ghl;ilAk;> gpz;lj;jpw;Ff; fhuzkhd  fU tpe;Jtpd; Njhw;wj;ijAk; 
czh;j;Jfpwhh; 
             cjaj;jpy; te;Jtpy; xq;F Fz;lypAk;  
          cja Fbypy;  tape;jtk; xd;ghd; 
          tpjpapy; gpukhjp fs;kpF rj;jp 
         fjpapw; fuzq; fiyit fhpNa
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    According to siddhars 1 drop of venner made from 80 drops of senner (blood). 
1drop of vindhu made from 80 drops of venner. So 6400 drops of senner (blood) 
needed to make one drop of vindhu. 
(23) 
Tpe;J GzHr;rpapd; gad; : 
                                  Gwk; mfk; vq;Fk; GFe;JxspH Tpe;J 
               epwk; mJ ntz;ik:epfo; ehjk; nrk;ik 
               cw kfpo; rj;jp rptghjk; MAs; 
               jpwndhL tPL mspf;Fk; nray; nfhz;Nl.  
 
                                             
      The colour of semen s purely white & the colour of ovum is red . the joining 
of the both , semen &ovum leading to , fertilization of ovum by the sperm to form 
new energy, foetus. 
Tpe;jpdhy; gpwg;G: 
              Je;ij tpj;jjp rhuj;jpyutkhAjpj;J 
              Ie;J G+jk; jhf cg;gJ cth; glh;e;J 
              Tpe;J Nkygp tUjy; ij khrp gq;FdpAk; 
              Tpe;J thYjpj; jpyfpa ehjKkpJNt(24)  
 
                           ;-jpUts;St ehadhh; itj;jpa rpe;jhkdp 800 
 
Birth by semen : 
         According to the saint Thiruvalluvar , The semen of male partner helps to 
embryo after fertilization . The embryo grows up by the influence of 5 elements ( 
pancha bootham ).The birth of foetus should takes place in the tamil month named 
“thy” and so the fertilization must be on the month of “maasi & panguni”  
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AETIOLOGY: 
 
MALE INFERTILITY DUE TO INFECTIONS: 
The complications of the karumpanisai ammai are,  
 - Death of sperm cells in male 
 - Abortion in pregnant women  
 - Produce sterility in both men and women.
(28) 
 
MALE INFERTILITY DUE TO TRAUMATIC LESIONS: 
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TOPICS RELATED TO MALE INFERTILITY IN SIDDHA LITERATURE: 
SUKKILA VATHAM: 
         Emaciation, constipation, oliguria, bleeding from the nose, phlegm accumulation 
due to increased kapham,breathlessness,loss of taste. All the symptoms are associated 
with affected sukkilam, according to yugi. 
(32) 
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DIAGNOSTIC METHODS IN SIDDHA SYSTEM: 
UDAL KATTUGAL: (SEVEN PHYSICAL CONSTITUENTS) 
 
1. SAARAM – CHYLE (PLASMA): 
           It is responsible for the growth & development. It keeps the individual in good 
spirit and nourishes the blood. 
In Aan Maladu, Saaram affected. 
 
2. SENNEER – BLOOD: 
          Blood imparts color to the body and nourishes the muscle for the ability. 
 
3. OON – MUSCLE: 
          Gives shape to the body. 
 
4. KOZHUPPU – FAT: 
          It helps in lubricating the different organs and maintains oily matter of the body. 
 
5. ENBU – BONE: 
         It supports the system and responsible for the posture movement of the body. 
 
6. MOOLAI – MARROW: 
         It fills the bone cavity, nourishes semen and imparts strength, endurance and 
shiny appearance. 
 
7.SUKKILAM (SPERM): 
          It is responsible for the reproduction. 
In Aan Maladu, Sukkilam affected.
(34) 
 
Rf;fpy Fzk;: 
cz;ikahd Rf;fpy Kghakh apUejJk;. 
ntz;ikahfp ePupNy tpiue;J ePujhdJk; 
jz;ikahd fhaNk jupj;JUt khdJk; 
njd;ikahd Qhdpfs; njspe;Jiuf;f NtZNk .  
                              - rptthf;fpah; 
                                                                     (Sivavakkiar padal –moolamum uraiyam ) 
              At the time of copulation, the semen is ejaculated.  The prostatic fluid gives 
the semen a milky appearance.  In the early minutes after ejaculation, the sperm 
remains immotile, possibly because of the viscosity of the coagulum.  As the 
coagulum dissolves the sperm become highly motile.
(36) 
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Rf;fpyk; Fiw Fzk; 
     Gzu;r;rpapy; ntz;zPUk; RNuhzpjKk; nghWj;Jg; nghWj;Jg; Jspj; 
Jspaha; tpOjy;> my;yJ nre;ePu; ntspg;gly;> tpijapy; Fj;jYld; typ> 
Fwpapy; mow;rp kpFjpg;gly;. 
             At the time of copulation insufficient quantity of semen is ejaculated with 
pain, pricking pain in the scrotum, irritation of the penis
[36]
. 
Examination of semen: 
 If the semen is, 
1. White and akin to the butter, it is excellent. 
2. White and akin to curd, it is very good. 
3. White and akin to the milk, it is good. 
4. White and akin to the butter milk, it is fair 
5. Akin to the honey in color and consistency, it is average. 
6. Akin to the ghee in color and weight, it is poor. 
7. Akin to the toddy is color and weight, it is very poor. 
8. Akin to the water, it is very bad.
(38) 
                                                   -        -1
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Uyir thathukkal / Mukkutram: 
           These are all the main three pillars which functioning the body with an 
equilibrium state. Any disturbance in that state leads to diseased condition in our 
body. 
The three pillars are, 
1. Vali 
2. Azhal 
3. Iyam 
 
1. Vali or Vaayu: 
           Vali is not mere wind, but also that which causes motion, energy and sensation 
of every cell in the body. Vaayu relates to nerve force. It is responsible for all 
movements in the mind and the body. In human body it controls the Gnanendriyam 
(sensory actions) & Kanmendriyam (motor activities) 
 
Vali generally lives in, 
Abanan, Edakalai, Kamakodi, Undhiyin Keezh Moolam, Hip region, Bones, Muscles, 
Nerves, Joints, Skin, Hair follicles, Stools. 
 
Varieties of Vali: 
According to their location and functions they are classified into 10 types. 
1. Uyirkkaal (Pranan) 
2. Kezhnokkum Kaal (Abanan) 
3. Paravukaal (Viyanan) 
4. Melnokkum Kaal (Udhanan) 
5. Nadukkaal (Samanan) 
6. Naagan 
7. Koorman 
8. Kirugaran 
9. Devadhathan 
10. Thananjeyan 
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1. Uyirkkaal (Pranan)  
           It regulates the respiratory, cardiac and digestive system. By joining with 
pingalai it forms azhal naadi. It is responsible for bio confusion in the body. 
 
2. Kezhnokkum Kaal (Abanan)  
         It regulates the defecation, micturition, menstruation, parturition and ejaculation. 
It corresponds to the pelvic plexus and the lower part of the gut. 
 
3. Paravukaal (Viyanan)  
          It spreads all over the body and all nerve endings. It regulates constriction and 
relaxation of the voluntary and involuntary muscles. The neurological problems were 
due to this Vaayu. It spreads the nutrients to all over the body from the digested food. 
 
4. Melnokkumkaal (Udhanan) 
          It is responsible for speech, vomiting, hiccough and sneeze. 
 
5. Nadukkaal (Samanan): 
         It is responsible for digestion and it spreads the nutrients to all over the body. 
Joining with suzhumunai it forms the Kabha naadi. It neutralizes the other four 
Vaayus. 
 
6. Naagam: 
          It is responsible for the intelligence and derangement of this Vaayu causes 
impaired memory. It helps to opening and closure of eyelids. 
 
7. Koorman: 
          This is responsible for the vision, Yawning and Lacrimal secretions. 
 
8. Kirugaran: 
           It is responsible for salivation, nasal secretion, hunger, sneeze, cough and 
concentration. 
    
9. Devadhathan: 
          It is responsible for laziness and anger. 
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10. Thananjeyan: 
         It produces swelling all over the body and leaves from cranium only after the 
3rd day after death. It is responsible for the decay of the body after death. 
In Aan Maladu,Kezhnokkum Kaal & Paravukaal affected.
(40) 
 
II.Azhal: 
         This is nothing but the characteristics of fire such as burning, boiling and 
heating etc. It corresponds to the functions so thermo genesis production of heat 
necessary to maintain integrity of the human circulatory system. Azhal is classified 
into 5 types. In mainly governs enzymes & hormones. 
Azhal lives in: 
         Between heart & the navel, Sweat, lymph, blood, stomach, urinary bladder, 
saliva eye and skin 
In Aan Maladu, Sathaga Pitham affected.
(40) 
 
           
                 Name 
 
                Location 
  
              Function 
1.Aakkanal 
(Analagam) 
 Stomach, Small Intestine   Dissolvent& Digestive 
2.Vanna eri 
(Ranjagam) 
  Liver, Spleen, Stomach   Colouring, Pleasing,   
           Gratifying              
3.Aatralangi 
(Sathagam) 
              Heart    Effective Efficient 
4.Nokkazhal 
(Alosagam) 
              Eyes    Seeing, Consideration 
5.Ollolithee 
(Prasagam) 
              Skin  Complexion Of The Skin 
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Iyyam: 
           It imparts moisture. Iyam is located in samanan semen, head, tongue, flat, bone 
marrow, blood, nose, chest, nerves, brain, large intestine, eyes, stomach& pancreas. 
                 
                Name 
 
           Location 
 
                       Function 
1.Alli Iyam 
(Avalambagam) 
             Lung         Supports all the others 
2.Neerpi Iyam 
(Kilethagam) 
           Stomach Moistens and nourishes the 
food 
3.Suvaikanna Iyam 
(Pothagam) 
           Tongue         Take care of perception 
4.Niraivu Iyam 
(Tharpagam) 
             Head       Refrigerant effect of eyes 
5.Ondri Iyam 
(Sandhigam) 
            Joints Stability, lubrication, 
movement of joints     
 
In Aan Maladu, Tharpagam & Santhigam affected.
(40) 
 
ENN VAGAI THERVUGAL  
 
                It is the unique and special method in siddha .Envagai thervugal is the 
specialty of siddha diagnosis. These are the instruments for the physician to diagnose 
disease.
(42) 
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NAADI: 
The three uyir thaadukkal felt through the pulse is called naadi 
Naadi   Vaayu   Uyir thathu        Ratio 
Edakalai + Abanan - Vatham –  1 
Pinkalai + Piranan - Pitham  –  ½ 
Suzhumunai + Samanan - Kapam  –  ¼ 
PARISAM: 
          Observations by touch, temperature, sensory impairments, masses, nodes, 
swelling and texture of the skin, pain, hardness, edematous and dullness shall be 
noted. 
NAA:  
          Signs and symptoms in the tongue are considered here. Size, appearance, 
thickness, color (pigmented, magenta) fissured (longitudinal, transverse) coated, 
geographical patches, oral hairy leukoplakia, candida, aphthous ulcer, sense of taste, 
saliva secretion. 
NIRAM: 
          The color of skin is mainly considered here but also the change in other organs. 
MOZHI: 
          The change in the normal sound of voice mainly uratha olli (Valithel), 
thazhntha olli (Melithal), physiological and mental status can also be noted during 
conversation. 
VIZHI: 
          Color, warm, burning sensation, irritation, visual perception 
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MALAM:  
            Nature, quantity, color, odour, froth, consistency are noted. 
MOOTHIRAM:  
            The urine examination is classified into two types. 
NEERKKURI: 
 
Urine is to be observed for the following characters 
 Niram (color) 
 Edai (specific gravity) 
 Manam (smell) 
 Nurai (froth) 
 Enjal (deposit)(45) 
 
NEIKKURI: 
It is an important test to assess the predominantly affected humour. 
 
                   On the day before the urine test one should take food, consisting of all the 
six tastes at the regular time based on one’s digestive fire; after a sound overnight 
sleep,urine should be collected in a glass ware and the test should be done before 90 
minutes from dawn. 
                  
                  A drop of oil is dropped at the center of urine (bowl) without any shake. It 
should be ensured that the Sunlight falls on it, but is not disturbed by the wind. A keen 
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observation of the oil drop suggests the condition of the patient. If the oil drop takes 
the shape of a snake, it indicates Vaadha disease.  
               If it spreads like a ring it indicates Pitha and if it stands like a pearl it 
indicates Kapha disease.If there is a combined shape like a ring in a snake, or snake in 
the ring, snake and a pearl or a pearl in the ring, it indicates combined derangement of 
humors. White layer starts with disturbed Azhal and eventually involves all the three 
uyir thathus -thus resulting in various patterns of oil spread in the urine surface.
 
NOI NEEKAM (TREATMENT): 
              In Siddha system the main aim of treatment is not only for the removal of 
Physical illness but also the mental illness. Treatment is considered with prevention 
and improvement of the general body condition (rejuvenation) also. 
This is said as follows 
Kappu  - Prevention 
Neekkam  - Treatment  – curative 
Niraivu  - Restoration  – promotive 
While treating the disease the following principles must be noted. 
                 So it is essential to diagnosis properly to know about the etiology, the 
nature of the patient, the severity of illness, the seasons and the time of the occurrence 
of the disease. 
 
LINE OF TREATMENT: 
1. To bring the three Kutrams in equilibrium 
2. Medicine (Internal) 
3. Diet and advise 
TO BRING THE THREE KUTRAMS IN EQUILIBRIUM: 
               Since Siddha system of medicine is based on Mukkutra theory, the purgation 
(Kalichal Maruthuvam) was given by for the vitiation of three humours. 
 
               Agasthiyar Kuzhambu 65mg was administrated at early morning as a 
purgative in the prior day of treatment. 
tPuPatpUj;jp R+uzk;
                                                                                                     SIDDHA ASPECT 
 
Veeriya viruthi Chooranam for Aan Maladu  Page 20 
 
YOGA AND RELAXATION THERAPY: 
                 Yoga has been practiced in India for a number of centuries. There are 
several methods of yogic practice originating from different school of thoughts. 
Yogic exercises improve the psychological functions of the individual
(46)
. I shall 
deal with only such asanaas are useful in curing ailments and maintaining good 
health for the male infertility. 
1. SARVANGASANA: 
 
 
 
                It is stimulates the pituitary and thymus glands and keeps the prostate 
gland healthy. This asana keeps the sex glands healthy. Sexual weakness in the case 
of male can be overcome by the practice of asana. 
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2. SIRASASANAM: 
 
 
                   Sirasasanam will prevent or give relief in neurasthenia, dyspepsia, seminal 
weakness, spermatorhoea, varicose veins. It will prevent the enlargement of prostate 
gland. 
3. SAVASANAM: 
 
 
 
                Savasanam is a Powerful Tranquilizer. It pacifies the body and a mind by 
eliminating muscular, Nervous, Mental and Emotional tension almost immediately. 
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4. BHADRASANA: 
 
 
 
                  It promotes fresh Blood supply to Urogenital organs. It will effectively 
cure Nocturnal discharges and sexual debility. 
 
5. DHANURASANA: 
 
 
 
It improves functions of the reproductive system in male and female. 
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6. PASCHIMOTTASANA: 
 
 
 
Relieves dyspepsia, Strengthens urogenital system. 
7. VIPARETHA KARANI: 
 
 
 
It is called as “Sakala Roga Nivarini” as it is curing all diseases. 
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8. PARSVAKONASANA: 
 
 
 
Expands the chest. Knee pain, Back pain are eradicated.Nervous system is 
stimulated. Impotency is corrected. 
9. ARDHA HALASANA: 
 
 
Digestion is improved. Liver, spleen, kidneys and reproductive organs are 
activated. 
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MUDHRAS FOR MALE INFERTILITY: 
1. YOGA MUDRA: 
 
 
 
             Yoga Mudra tones up the pelvic organs on account of the pressure of the 
heels on the groins. It is useful in seminal weakness. 
2. ASWINI MUDRA: 
            Aswini Mudra gives tone to the reproductive organs and Nerves and 
removes seminal insufficiency and sterility.
(47) 
 
-Yoga for health, Pg no:23-94 
 
PRANAYAMA: 
 It gives a feeling of freshness, energy and lightness of body and mind. 
 Strengthens the lungs. Increases its capacity and cures the disorders. 
 Digestion is improved. 
 Excretory system is stimulated. Toxins are removed from the body. 
 Skin tone is well maintained. 
 All the endocrine glands are stimulated. 
 It makes the nervous system more energetic. 
 It increases concentration and helps meditation.(48) 
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COOLING PRANAYAMA: 
            They are Cooling Pranayamas because of their cooling effect, and the help in 
calming down the mind by removing the mental anxiety & tension.
(48) 
 
MEDITATION: 
            It makes the mind calm and steady. It helps us to face the battle of life. It kills 
the pain and sorrow. It is a powerful nervine tonic. It increases memory power. It 
increases social harmony. It prevents and cures all psychosomatic diseases. It provides 
a healthy happy, long life. It gives positive attitude towards life. It increases creativity 
and alertness. It helps to fight the stress successfully and quickly. It increases will 
power and so one is able to overcome bad habits.
(48) 
 
DIET AND ADVICE: 
DIETS TO BE ADDED:  
KARPAM:  
 
 
 
 
VEGETARIAN DIET: 
 
 
 
 
 
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NON - VEGETARIAN DIET: 
 
 
  (50) 
 
DIETS TO BE RESTRICTED: 
 
 
 
 
 
 
 
 
PATIENTS ADVICED TO FOLLOW: 
kq;ifaiu $l Ntz; a fhyk;: 
 
                 Nra;Ak; mstpy;> jpUehd; K$h;j;jNk 
                 va;Ak;  fiy> fhyk;> ,e;J gUjpfhy; 
                 iea;Ak; ,lj;J Xb> ehd; fhkDhy; newp 
                 nra;f> tyk; ,lk; jPh;e;J tpLfNt.  
                                                                            
 
Time for coitus: 
             It is noted that 6 hours before sun rising is the apt time for sexual intercourse. 
During ejaculation it is better to maintain our breath either in idakalai/ pinkalai/ 
suzhumunai to make the purpose better. 
 
Tpe;J xopahjgb Gzh;jy;:                         
                              Nahfk; mt;tpae;J xopahtif Gzh;e;J 
             Mfk; ,uz;Lk; fye;jhYk Mq;F cwhg; 
             Nghfk; rptNghfk;;:Nghfp ew;Nghfkhk; 
             Nkhfk; nfl Kaq; fhh; %lh;khjh;f;Nf 
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State of orgasm: 
                and it is a kind of art &stage of yoga , that is to reach the stage of orgasm in 
female without losing a drops of semen. 
 
Tpe;J ePf;fk; $lhJ: 
             Tpj;Jf;Fw;W cz;ghd; tpisT mwpahjtd; 
             Tpj;Jf;Fw;W cz;zhky;> tpj;J Rl;L cz;gtd; 
             Tpj;Jf;Fw;W cz;ghdpy;> NtW myd; <w;wtd; 
             Tpj;Jf;Fw;W cz;zhky;> tpj;J tpj;jhd; md;Nw . 
                                     
 
                 it is important that seeding the seeds , instead of eating it by frying/raw ,to 
get the maximum benefits of this . similar to that everyone should utilize the semen as 
purposeful one, without losing it unnecessarily.  
          ; 
 
 
 
 
 
        
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                                               MALE INFERTILITY 
DEFINITION: 
 
                   Inability to produce offspring is called infertility. It is the inability to 
conceive a child by natural process or the inability to carry a pregnancy till the 
completion of term. Male infertility refers to the inability of a male to achieve a 
pregnancy in a fertile  female.  In  humans  it  accounts  for  40-50%  of infertility. 
Male  infertility is commonly due to deficiencies in the semen, and semen quality is 
used as a surrogate measure of male fecundity. 
 
                     According to statistics collected from The World Health Organization 
(WHO) estimates that 60 to 80 million couples worldwide currently suffer from 
infertility
[12]
. The prevalence of infertility in the general population is 15%–20%. Of 
this, the male factor is responsible for 20%–40%[53]. In Indian couples seeking 
treatment, the male factor  is  the  cause  in  approximately  23%
[54]
. In  a  World  
Health  Organization multicenter study, 45% of infertile men were found to have 
either oligo-zoospermia or azoospermia
[55]
. A  study  from  a  tertiary  care  
hospital  in  India  reported  58% azoospermia and 24% oligozoospermia in infertile 
men
[56]
. 
INFERTILITY CAN BE OF THREE DIFFERENT TYPES:  
PRIMARY INFERTILITY: 
                      When a woman has never achieved conception in her life it is 
known as Primary Infertility. 
 
SECONDARY INFERTILITY: 
 
                       When a woman has given birth to a child in the past but is facing 
difficulty to conceive again it is called Secondary Infertility. 
RECURRENT MISCARRIAGE: 
 
                       Women who experience recurrent miscarriages may also receive a 
diagnosis of  infertility  if  they  experience  two  or  more  successive  miscarriages.  
While miscarriage is not uncommon (occurring in up to 25% of recognized 
pregnancies),  
less than 5% of women will experience two miscarriages in a row, and less than 1% 
three or more successive miscarriages. 
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ETIOLOGY: 
 
                 Factors relating to male infertility include:- 
 
PRE TESTICULAR CAUSES: 
 
a) Hypothalamo pituitary diseases 
b) Hyperprolactinemia 
c) Isolated FSH deficiency 
 
d) Congenital hypogonadotropic syndrome 
 
e) Exogenous hormones (estrogen- androgen excess) 
 
f) Glucocorticoid excess 
 
g) Hyper – and hypothyroidism 
 
h) Drugs like phennytoin, androgens and estrogens 
i) Alcohol, smoking 
j) Strenuous riding (bicycle riding, horseback riding) 
 
TESTICULAR FACTORS: 
 
a) Testicular atrophy  
b) Cryptorchidism 
c) Varicocele  
d) Trauma 
e) Hydrocele  
f) Mumps 
g) Malaria 
 
h) Spermatogenesis arrest 
 
POST TESTICULAR CAUSES: 
 
a) Vas deferens obstruction 
 
b) Lack of Vas deferens, often related to genetic markers for Cystic Fibrosis 
c) Infection, e.g. prostatitis 
d) Retrograde ejaculation  
e) Hypospadias 
f) Impotence 
 
g) Acrosomal defect/egg penetration defect [57]. 
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ANATOMY OF MALE REPRODUCTIVE ORGANS 
 
           The male reproductive system includes the testis, epididymis, ductus 
(vas)deferens, seminal vesicles, prostate and penis 
 
TESTES: 
                      The testes are the primary reproductive organs or gonads in the male. 
They are ovoid reproductive and endocrine organs responsible for sperm production. 
They are suspended in the scrotum by scrotal tissues including the dartos muscle and 
the spermatic cords. Average testicular dimensions are 4-5 cm in length, 2.5 cm in 
breadth and 3cm in antero posterior diameter; their weight varies from 10.5-14g. The 
left testis usually lies lower than the right testis. Each testis lies obliquely within the 
scrotum, its upper pole tilted antero laterally and the lower posteromedially 
         
The testis is invested by three coats; 
                 Tunica vaginalis 
                Tunica albuginea  
                Tunica vasculosa 
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TUNICA VAGINALIS 
                 It is the lower end of the peritoneal process vaginalis, whose formation 
proceeds the decent of the fetal testis from the abdomen to the scrotum. The 
visceral layer covers all the aspect of the testis except most of the posterior aspect. 
The more extensive parietal layer reaches below the testis and ascends in front of and 
medial to the spermatic cord. The Inner surface of the tunica vaginalis has a smooth, 
moist mesothelium the potential space between its visceral and parietal layers is 
termed the cavity of the tunica vaginalis. 
 
TUNICA ALBUGINEA 
 
               It is a dense, bluish white covering for the testis. It is composed mainly of 
interlacing bundles of collagen fibres. It is covered externally by the visceral layer of 
the tunica vaginalis, except at the epididymal head and tail and the posterior aspect of 
the testis, where vessels and nerves enter. It covers the tunica vasculosa and, at the 
posterior borders of the testis, project in to the testicular interior as a thick, incomplete 
fibrous septum, the mediastinum testis. 
TUNICA VASCULOSA 
 
              It contains a plexus of blood vessels and delicate loose connective tissue, and 
extend over the internal aspect of the tunica albuginea, covering the septa and 
therefore all the testicular lobules. 
EPIDIDYMIS 
                The epididymis lies posteriorly and slight lateral to the testis, with vas 
deferens along its medial side. It has an expanded head superiorly, a body and a 
tail. Its overall length is 6-7 cm and it consists of the single convoluted ductus 
epididymis formed by the union of the efferent ductus of the testis, which attach to the 
rete testis. From the tail the vas deferens ascends medially to the deep inguinal ring, 
within the spermatic cord
[58]
.               
TESTICULAR AND EPIDIDYAMAL APPENDICES 
               At the Upper extremities of the testis and epididymis are two small stalked 
bodies the appendix testes and appendix epididymis. They are developmental 
remnants of the para meso nephric ducts (mullerian) ducts and meso nephrons 
respectively. 
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TESTICULAR TORSION 
 
              The testis and epididymis are usually fixed to their surrounding tissues. In 
some  patients  this  fixation  may be  insufficient,  a  condition  which  allows  the 
structures to twist within the tunica vaginalis. This is termed testicular torsion and 
normally results in severe scrotal pain. Fertility may be affected by an episode of 
torsion. 
 
SEMINAL VESICLES: 
 
              The two seminal vesicles are sacculated, contorted tubes located between the 
bladder and rectum. Each vesicle is 5 cm long, somewhat pyramidal, the base being 
directed up and posterolaterally. Essentially the seminal vesicle is a single coiled tube 
with irregular diverticula. The coils and the diverticula are connected by the fibrous 
tissue. The diameter of the tube is 3-4 mm and its uncoiled length is 10-15cm
[59]
. 
 
VAS DEFERENS: 
 
              It is a muscular tube, 45 cm long, which conveys sperm to the ejaculatory 
ducts, and its distal continuation of the epididymis, starting at the epididymal tail. At  
first  it  is  very  tortuous,  but  it  becomes  straighter,  and  ascends  along  the 
posterior aspect of the testis. From the superior pole of the testis it ascends in the 
posterior  part  of  the  spermatic  cord,  and  traverses  the  inguinal  canal.  At  the 
internal inguinal ring the vas deferens leaves the cord, curves round the lateral side of 
the inferior epigastric artery. It then turns back and inclines slightly down and 
obliquely across the external iliac vessels to enter the lesser pelvis. It crosses the 
ureter and bends acutely to pass anteromedially between the posterior surface of 
the bladder and upper pole of the seminal vesicle. It finally descends to the base of 
the prostate, where it joins to the duct of the seminal vesicle at an acute angle to form 
the ejaculatory duct
[59]
. 
EJACULATORY DUCTS 
               The ejaculatory ducts are formed on each side by the union of the duct of 
the seminal vesicle with ampulla of the vas. Each is almost 2 cm in length, starts from 
the base of the prostate, runs anteroinferiorly between its median right or left lobes. 
SPERMATIC CORD: 
 
                At the testis traverse the abdominal wall into the scrotum during early life, 
it carries its vessels, nerves and vas deferens with it. These meet at the deep 
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inguinal ring to form the spermatic cord, which suspends the testis in the scrotum and 
extends from the deep inguinal ring to the posterior aspect of the testis. The left 
cord is a little longer than the right. Between the superficial ring and testis the cord is 
anterior to the rounded tendon of adductor longus. The spermatic cord contains the 
vas deferens, testicular artery and veins, cremastric artery and artery to the vas 
deferens, genital branches of the genitofemoral nerve, cremastric nerve and 
sympathetic components of the testicular plexus. 
ABERRANT DUCTLESS: 
 
               A narrow, blind caudal aberrant ductile often occurs usually connected with 
the caudal part of the epididymal duct or with the start of the vas deference. 
PARADIDYMIS: 
 
              The  paradidymis  is  a  small  collection  of  convoluted  tubules  found 
anteriorly in the spermatic cord above the epididymal head. 
SCROTUM 
                The scrotum is a cutaneous fibro muscular sac containing the testes and 
lower parts of the spermatic cords. It hangs below the pubic symphysis between 
the anteromedial aspects of the thighs. It is divided in to right and left halves by a 
cutaneous  raphe,  which  continues  ventrally  to  the  inferior  penile  surface  and 
dorsally along the midline of the perineum to the anus. 
 
               It consists of skin, dartos muscle and external spermatic, cremastric and 
internal spermatic fasciae. The scrotal skin is thin, pigmented and often rugose. It 
bears thinly scattered, crisp hairs. It has sebaceous glands, numerous sweat glands, 
pigment cells and nerve endings.   The left side of the scrotum is usually lower 
because the left spermatic cord is longer. 
PENIS 
 
            The penis is the male organ of copulation, consists of an attached root in 
the perineum and a free, normally pendulous body which is completely enveloped in 
skin. The penile skin is remarkably thin, dark and loosely connected to the 
tunica albuginea. At the corona of the penis it is folded to form the prepuce or 
foreskins, which variably overlap the glans. The prepuce and glans penis enclose a 
potential cleft, the preputial sac and the two shallow fossae flank the frenulum. 
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Root of the penis: 
 
           The root of the penis is situated in the superficial perineal pouch. It is consists 
of three masses of erectile tissue in the urogenital triangle, namely the two crura and 
one bulb, each crus is firmly attached to the margins of the pubic arch and is 
covered by the ischiocavernosus. The blub is attached to the perineal membrane in 
between the two crura. It is covered by the bulbospongiosus. 
 
Body of the penis: 
 
           The body of the penis composed of three elongated masses of erectile 
tissue. During erection of the penis these masses become engorged with blood 
leading to considerable enlargement. When flaccid the penis is cylindrical, but 
when erect it is triangular with rounded angles. 
Corpora cavernosa: 
 
                  The corpora cavernosa of the penis form most of the body. On the urethral 
surface their combined  mass  has a wide median groove, adjoining the corpus 
spongiosum. 
Corpus spongiosum: 
 
               The corpus spongiosum of the penis is traversed by the urethra. Near the 
end of the penis it expands in to a somewhat conical enlargement, called the glans 
penis
[58]
. 
 
REPRODUCTIVE AND HORMONAL FUNCTIONS OF THE MALE: 
 
           The reproductive functions of the male can be divided in to three major 
subdivisions: 
 
(1) Spermatogenesis 
 
(2) Male sexual cycle 
 
(3) Regulation of male reproductive functions by various hormones 
 
GAMETOGENIC FUNCTIONS OF TESTES – SPERMATOGENESIS: 
 
                  The production of gamete cells is called the gametogenic function. 
Spermatogenesis is the process by which spermatozoa are developed from the 
primitive germ cells called the spermatogonia of testis. 
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STAGES OF SPERMATOGENESIS: 
 
Spermatogenesis occurs in four stages: 
 
1. Stage of proliferation 
 
2. Stage of growth 
 
3. Stage of maturation 
 
4. Stage of transformation. 
 
1. STAGE OF PROLIFERATION: 
 
                 The spermatogonia near the basement membrane of seminiferous tubule 
are larger. Each spermatogonium contains diploid number of chromosomes (23 
pairs in man) One member of each pair is from maternal origin and the other one 
from paternal origin. During the proliferative stage, the spermatogonia divide by 
mitosis without any change in chromosomal number. During this stage, the 
spermatogonia migrate along with sertoli cells towards the lumen of seminiferous 
tubule. 
2. STAGE OF GROWTH: 
                     In this stage, the primary spermatocyte grows into a large cell. Apart 
from growth, there is no other change in spermatocytes during this stage 
3. STAGE MATURATION: 
 
                  After reaching the full size, each primary sepermatocyte quickly 
undergoes meiotic or maturation division, which occurs in two stages. 
I. First stage – two secondary spermatocytes are formed 
 
II. Second stage – each secondary spermatocyte divides into two spermatids. 
 
 
4. STAGE OF TRANSFORMATION: 
 
              The spermatids do not divide further but transform into matured 
spermatozoa (sperms) by a process called spermatogenesis. The changes which take 
place during maturation of sperm are,  
a) Condensation of nuclear material 
b) Formation of acrosome. Mitochondrial spiral filament tail structure 
c) Removal of extraneous cytoplasm 
   The matured sperms are released from sertoli cells into the  lumen of seminiferous 
tubules. The process by which the sperms are released into the lumen of seminiferous 
tubules. For the transport out of testis is called, spermination. 
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      STAGE OF SPERMATOGENESIS- NECESSARY HORMONES 
 
Stage of spermatogenesis Hormones necessary 
1. Stage of proliferation FSH, Growth  Hormone 
2. Stage of growth Testosterone, Growth Hormone 
3. Stage of maturation Testosterone, Growth Hormone 
4. Stage of transformation Testosterone, Estrogen 
 
 
ROLE OF HORMONES IN SPERMATOGENESIS: 
 
              Spermatogenesis is influenced by many hormones which act either directly 
or indirectly. The hormones necessary for spermatogenesis are, 
1. Follicle stimulating hormone (FSH) 
 
2. Testosterone 
 
3. Estrogen 
 
4. Luteinizing hormone (LH) 
 
5. Growth hormone (GH) 
 
           1. FSH: 
 
             FSH is responsible for the initiation of spermatogenesis. It binds with Sertoli 
cells and induces the proliferation of spermatogonia.  It also stimulates formation of 
estrogen and androgen binding protein from sertoli cells. 
 
2. TESTOSTERONE: 
 
              It stimulates the spermatogenesis. It is also necessary for the formation of 
secondary spermatocyte from primary spermatocyte. 
 
 3. ESTROGEN: 
 
                   This is secreted by Sertoli Cells. This is also necessary for spermeogenesis 
 
 4. LH: 
                   This hormone is essential for the secretion of testosterone from Leydig 
cells 
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5. GH: 
               GH is essential for back ground metabolism of testis. It is also necessary for 
proliferation of spermatogonia. In pituitary dwarfs, the spermatogenesis is severely 
affected 
 
 
MATURATION OF SPERM IN THE EPIDIDYMIS: 
 
            After formation in the seminiferous tubules, the sperm require several days to 
pass through the 6-meter long tubule of the epididymis. Sperm removed from the 
seminiferous tubules and from the early portions of the epididymis are non-motile, 
they cannot fertilize an ovum. However after the sperm have been in epididymis for 
some 18 to 24 hours they develop the capability of motility even though several 
inhibitory proteins in the epididymal fluid still prevent final motility until after 
ejaculation. 
 
STORAGE OF SPERM: 
 
              The two testes of the human adult form up to 120 million sperm each day. A 
small quantity of these can be stored in the epididymis but most are stored in the 
vas deferens. They can remain stored maintaining their fertility for at least a month. 
During this time they are kept in a deeply suppressed inactive state by multiple 
inhibitory substances in the secretions of the duct. Conversely with a high level of 
sexual activity and ejaculations storage may be no longer than a few days. After 
ejaculation the sperm become motile and they also become capable of fertilizing the 
ovum a process called maturation. The sertoli cells and the epithelium of the 
epididymis secrete a special nutrient fluid that is ejaculated along with sperm. This 
fluid contains hormones and enzymes and special nutrients that are essential for sperm 
maturation. 
 
PHYSIOLOGY OF THE MATURE SPERM: 
 
                     The activity of sperm is greatly enhanced in a neutral and slightly alkaline 
medium as exists in the ejaculated semen but it is greatly depressed in a mildly acidic 
medium. A strong acidic medium can cause rapid death of sperm. The activity of 
sperm increases markedly with increasing temperature. Although the sperm can live 
for many weeks in the suppressed state in the genital ducts of the testes. Life 
expectancy of ejaculated sperm in the female genital tract is only 1 to 2days (24 to 48 
hours). 
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ROLE OF SERTOLI CELLS IN SPERMATOGENESIS: 
 
         Sertoli cells influence spermatogenesis by the following ways : 
 
1. Sertoli cells provide nutrition to the developing sperms. 
 
2. sertoli cells secrete estrogen, which is essential for spermatogenesis. 
 
3.   sertoli   cells   secrete   hormone  binding  proteins.   These  proteins   bind   with 
testosterone  and  estrogen  and  carry  the  hormones  into  the  fluid  of  somniferous 
tubules. 
4. sertoli cells make these hormones available for the maturation of sperms. 
 
FUNCTIONS OF SEMINAL VESICLE SECRETION: NUTRITION TO 
SPERMS: 
              The fructose and other nutritive substances from seminal vesicles are utilized 
by sperms after being ejaculated into female genital tract. 
 
CLOTTING OF SEMEN: 
 
              The fibrinogen from secretions of seminal vesicle is converted in to the 
coagulum as soon as semen is ejaculated. 
 
ON FERTILIZATION: 
 
              The prostaglandin of seminal vesicle fluid enhances the fertilization of 
ovum by the following processes: 
               1. Increasing the receptive capacity of cervical mucosa for Sperms. 
 
                2. Causing reverse peristaltic movement of uterus and fallopian tubes. 
This, in turn, increases the rate of transport of sperms in female genital tract during 
coitus.  
 
FUNCTIONS OF PROSTATIC FLUID: 
MAINTENANCE OF SPERM MOTILITY: 
 
               The prostatic fluid provides optimum  pH for the motility of sperms. Due to 
the metabolic end products from sperm, the fluid in vas deferens acidic in nature. This 
inhibits the motility of sperms. The Vaginal secretions in females are highly acidic 
with a pH of 3.0 – 4.0. This also inhibits the motility of sperms. Generally, the sperms 
are non- motile at a pH less than 6.0.The prostatic secretion neutralizes the acidity of 
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vaginal secretions and maintains a pH of 6-6.5. At this pH the sperm become motile 
and chances of fertilization are enhanced. 
 
CLOTTING OF SEMEN: 
 
         The clotting enzymes in prostatic secretion cause conversion of fibrinogen into 
coagulum. It is essential for holding the sperms in uterine cervix. 
 
LYSIS OF COAGULUM: 
 
         The coagulum is dissolved by fibrinolysin of the prostate secretion so that the 
sperm become motile. 
 
SEMEN: 
 
         Semen is a white or grey fluid that contain spermatozoa .It is the collection of 
fluid from testis, seminal vesical, prostate and bulbourethral gland. Semen is 
discharged during sexual act and the process of discharge is called ejaculation. At the 
time of ejaculation, human semen is liquid in nature. Immediately, it coagulates and 
some time it undergoes a secondary liquefaction. 
 
PROPERTIES OF SEMEN: 
 
1. Specific gravity: 1.028 
 
2. Volume: 2 to 6 ml/ejaculation 
 
3. Reaction: 
 
Alkaline pH of 7.5.the alkalinity is due to the secretions from prostate. 
 
COMPOSITION OF SEMEN: 
 
Semen contains 
 
1. Sperms                                                        : 10% 
 
2. Products from seminal vesicle                   : 60% 
 
3. Products from prostate gland                     : 30% 
 
 
SPERM: 
 
           The total count of sperm is about 100 to 150 million /ml of semen.   Male 
sterility occurs, when the sperm count is less than 15 million/ml. After ejaculation 
of sperm, the survival time is only about 24 to 48 hours at a temperature equivalent to 
body temperature.  The  rate  of  motility  of  sperm  in  female  genital  tract  is  
about3mm/minute. The sperm reach the fallopian tube in about 30 to 60 minute after 
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sexual intercourse. The Uterine contraction during sexual act facilitates the movement 
of sperms. 
 
                                                         
 
                                                                                                  
                                                                   
                                                             Semen 
 
  
 
                     
                                                                                                                                        
               Sperms 10%                                                  Seminal Plasma – 90% 
                                                                                                                                                                       
                                                                                                                               
 
 
                                           
 
Products from seminal vesicles – 60%                   Products from prostate gland – 30% 
 
                                                                                                                                                                                                
1. Ascorbic acid  6. Pepsinogen                 1. Acid phosphatase           9. Seminin 
 
 
2. Fibrinogen      7. Phosphorylcholine       2. Cholestrol                     10. Spermine 
 
 
3. Flavin            8. Prostaglandian(PGE-2) 3. Clotting enzymes           11. Bicarbonate 
 
 
4. Fructose         9. Citrate                         4. Fibrinolysin                  12.  Calcium 
 
 
5. Inositol          10. Citric acid                   5.  Glucose                       13. Citrate 
 
 
                                                                6.  Lactate dehydrogenase 14. Sodium 
    
 
                                                                7.  Phospholipids               15. Zinc 
 
 
                                                                 8.  Plasminogen activator 
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                                                            Sperm cell 
 
 
 
 
CAPITATION OF THE SPERMATION: 
 
               Mature sperm, even when they are coming out of the male genital tract are 
incapable of fertilizing the ovum unless the further changes or capitation takes place 
for a variable period 1 to 10 hours in the female genital tract. The membrane of the 
sperm thus become progressively permeable to calcium ion that enters in abundance 
to initiate the powerful whiplash forward movement of the flagellum or tail instead of 
its previous undulating motion. Calcium has a further role to bring about further 
chance in the acrosome intracellular membrane for helping to releasing its enzyme 
very rapidly in female genital tract. 
 
THE ACROSOME REACTION: 
 
          The lytic enzyme involved in the sperm penetration is mostly located in the 
anterior sperm head, whereas other such as acrosin are primary contained within the 
acrosome. The anterior surface of the head needs to be removed allowing liberation of 
acrosin before the sperm can be penetrating zona pellucida. Removal of this anterior 
surface of the head is the process called acrosome reaction. 
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MECHANISM OF ERECTION: 
 
           The male erectile response is a vascular event initiated by neuronal action and 
maintained by a complex interplay between vascular and neurological, and perhaps 
humoral phenomenons resulting in cascade of events. Erection of penis in simple 
terms consists of trapping pressurized blood within the confines of a limited space 
provided by the spongy corpora cavernosa. This blood – filled spaces relax and open 
up, allowing free inflow of blood leading to expansion of the chambers pulling the 
tunica albuginea tight. The tensed tunica albuginea makes the corpora hard (resistant 
to indentation) and rigid (resistant to flexion). Secondarily, it pinches off the veins 
(that normally let blood leave the chambers) trapping blood inside and contributing to 
the state of engorgement .The valves (actually flaps), according to some experts) that 
control the flow of blood, however are opened and closed by nerves that run through 
the spinal cord to the brain.  
            Activation by the nervous system causes a rapid increase in the blood flow 
into the penis. During erection, as blood flows into the penis, the holes in the spongy 
tissue in the penis get filled in with it. At the same time, flaps in the veins leading 
out of the penis enlarge, cutting off the outflow. Thus, more blood flows in than out, 
and the penis are compressed from the increased pressure from the erection itself. In 
addition, the heart rate and blood pressure increase the pressure of blood into the 
penis increases to maintain its hardness. 
 
MECHANISM OF EJACULATION: 
 
                     The emission phase is the first phase. It involves deposition of seminal 
fluid from the ampullary vas deferens, seminal vesicles and prostate gland into 
posterior urethra. The second phase is the expulsion phase. It involves closure of 
bladder neck followed by the rhythmic contractions of the urethra by pelvicperineal 
and bulbospongiosus muscle, and intermittent relaxation of external urethra 
sphincters. It is  believed  that  the  neurotransmitter  serotonin  (5HT)  plays  a central  
role  in modulating ejaculation. Several animal studies have demonstrated its 
inhibitory effect on ejaculation. Therefore, it is perceived that low level of 
serotonin in the synaptic cleft in these specific areas in the brain could cause 
premature ejaculation.    
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                   This theory is further supported by the proven effectiveness of selective 
serotonin reuptake inhibitors (SSRIs), which increase serotonin level in the synapse, 
in treating PE. Sympathatic motor neurons control. The emission phase of ejaculation 
reflex and expulsion phase is executed by somatic and autonomic motor neurons. 
These motor neurons are located in  the thoraco lumbar and  lumbo sacral spinal 
cord and are activated in a coordinated manner when sufficient sensory in a 
coordinated manner when sufficient sensory input to reach the ejaculatory threshold 
has entered the central nervous system. Several areas in the brain, and especially the 
nucleus paragigantocellularis, have been identified to be involved in ejaculatory 
control
[59]
. 
 
MALE SEXUAL HORMONE: 
 
The testes secrete the male sex hormones are called the androgens. The testicular 
Androgens are: 
1. Testosterone 
 
2. Dihydrotestosterone 
 
3. Androstenedione 
 
 
SOURCE OF SECRETION OF ANDROGENS: 
 
              The androgens are secreted in large quantities by testes and in small 
quantities by adrenal cortex. 
 
TESTES: 
 
              In testes, the androgens are secreted by the interstitial cells of leydig. This 
forms 20% of mass of adult testis, leydig cells are numerous in newborn male infant 
and in adult male after puberty. 
 
ADRENAL CORTEX: 
 
               Zona reticularis of adrenal cortex also secretes androgens called testosterone, 
androstenedione and dehydro-epiandrosterone. 
 
FUNCTION OF TESTOSTERONE: 
 
              In general, testosterone is responsible for the distinguishing characters of 
masculine body. In the fetal life, the tests are stimulated by human chorionic 
gonadotropins secreted by placenta. 
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SEX DIFFERENTIATION IN FETUS: 
 
              Testosterone is responsible for the sex differentiation. 
 
 
Mullerian Duct 
 
                  From this duct, female accessory sex organs like vagina, uterus and 
fallopian tube are developed. 
  
 
Wolffian Duct 
 
                   From  this,  male  accessory  sex  organs  like  epididymis,  vas  deferens  
and seminal vesicles are developed. 
 
.DESCENT OF TESTES: 
 
Initially, testes are developed in the abdominal cavity and are later pushed into the 
scrotum through inguinal canal just before birth. This is called the descent of 
testes. Testosterone is necessary for this. If a male child is born with undecended 
testes, the condition is called „cryptorchidism‟. 
 
FUNCTION OF TESTOSTERONE IN ADULT LIFE: 
 
Testosterone has two important functions in adult, 
 i. Effect on sex organs 
ii. Effect on secondary sexual characters 
 
 
ON SEX ORGANS: 
 
          Testosterone increases the size of penis, scrotum and the testes after puberty. 
 
 
ON SECONDARY SEXUAL CHARACTERS: 
 
Testosterone causes development of secondary sexual characters at puberty, which 
distinguishes the male from female. The secondary sexual characters developed by 
testosterone are as follows: 
 
MUSCULAR GROWTH: 
 
                    One of the most important male sexual characters is the development of 
musculature after puberty. The mass of the muscle increases by about 50% is due to 
the anabolic activity of testosterone on proteins. 
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BONE GROWTH: 
 
                  After puberty the bones grow in thickness with deposition of calcium. The 
increase in thickness is due to increase in total content of bone matrix which is 
because of protein anabolic activity of testosterone. Testosterone causes broadening 
of shoulders and it has a specific effect on pelvis which results in, 
a) Narrowing of pelvic outlet 
b) Lengthening of pelvis 
c) The funnel like shape of pelvis 
 
Pelvis in males is different from that of females, which is broad and ovoid in shape. 
Testosterone also causes early fusion of epiphyses of long bones with shaft.  
 
CHANGES IN SKIN: 
          Testosterone increases the thickness of skin over the entire body surface and 
the ruggedness of subcutaneous tissue. These changes in skin are due to deposition of 
proteins in skin. 
 
HAIR DISTRIBUTION: 
 
          The testosterone causes male type of distribution of hair on the body. i.e. hair 
growth over the pubis, along linea alba up to umbilicus, on face, on chest and other 
parts of the body like back, in males, the pubic hair has the base of the triangle 
downwards. 
 
CHANGE IN VOICE: 
 
         At puberty, testosterone causes hypertrophy of laryngeal muscles, the 
enlargement of larynx and lengthening and thickening of vocal cords. 
 
 
BASAL METABOLIC RATE: 
 
         At  the time of adolescence and  earlier part  of  adult  life,  the testosterone 
increases  the  BMR  rises  5  –  10%.  This  is  mostly  due  to  anabolic  effects  of 
testosterone on protein metabolism. 
 
ELECTROLYTE AND WATER BALANCE: 
 
          Testosterone increases  the retention  of sodium  by reabsorption in renal 
tubules. The action is very mild. 
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BLOOD: 
 
 
         After puberty, testosterone causes slight  increase  in  blood  volume  by 
increasing water content and by increasing the number of RBCs. 
 
CONTROL OF MALE SEXUAL FUNCTIONS BY HORMONES 
 
         A major share of the control of sexual functions in both male and female 
begins with secretion of gonadotropin releasing hormone (GnRH) by the 
hypothalamus. This hormone in turn stimulates the anterior pituitary gland to secrete 
two other hormones called the gonadotropic hormones. 
1.  Luteinizing  hormone  (LH)  –  This  hormone  is  essential  for  the  secretion  of 
testosterone from leydig cells. 
2. Follicle stimulating hormone (FSH) – it accelerates the process of spermatogenesis, 
Combination with testosterone. 
 
NEGATIVE FEEDBACK CONTROL OF TESTOSTERONE: 
 
            Testosterone regulates its own secretion by negative feedback mechanism. It 
acts on hypothalamus and inhibits the secretion of LHRH. When LHRH secretion is 
inhibited, LH is not released from anterior pituitary resulting in stoppage of 
testosterone secretion from testes. On the other hand, when testosterone production is 
low, lack of inhibition of hypothalamus leads to secretion of testosterone through 
LHRH and LH. 
 
ABNORMALITIES OF SEXUAL FUNCTION:  
ENLARGEMENT OF PROSTATE GLAND: 
Enlargement of prostate gland occurs due to: 
 
1.   Hyperplasia of glandular structures and connectivity tissues benign 
 
(non-malignant) enlargement 
 
2.   Cancer – malignant enlargement 
 
HYPOGONADISM IN MALES: 
 
            Hypogonadism is a condition characterized by reduction of functional activity 
of gonads. 
SIGNS AND SYMPTOMS: 
 
            The  clinical  picture  of  male  hypogonadism  depends  upon  whether  the 
testicular deficiency develops before or after puberty. 
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BEFORE PUBERTY: 
 
            The symptoms of hypogonadism are similar to those developed due to 
extirpation of testes before puberty. 
AFTER PUBERTY: 
 
            The symptoms are similar to those developed due to removal of testes after 
puberty. 
 
IN ADULT: 
 
            Hypogonadism caused by testicular disorder increases the gonadotropin 
Secretion and the condition called hypergonadotropic hypogonadism. Hypogonadism 
that occurs due to deficiency gonadotropin is called hypogonadotropic hypogonadism.  
 
FROHLICHS SYNDROME: 
            It is the disorder characterized by obesity and hypogonadism in adolescent boy 
also called adiposo genital syndrome or hypothalamic eunuchism. 
 
EFFECT OF TEMPERATURE ON SPERMATOGENESIS: 
 
                  Increasing  the  temperature  of  the  testes  can  prevent  spermatogenesis  
by causing   degeneration   of  most   cells   of  the   seminiferous  tubules   besides   
the spermatogonia. It has often be stated that the reason, the testes are located in 
the dangling scrotum is to maintain the temperature of these glands, below the 
internal temperature  of  the  body,  although  usually  only  about  2º  C  below  the  
internal temperature. On cold days scrotal reflexes cause the musculature of the 
scrotum to contract, pulling the testes close to the body to maintain this 2º C 
differential. Thus the scrotum theoretically acts as a cooling mechanism for the testes.  
 
CRYPTORCHIDISM: 
                 Cryptorchidism means failure of the testis to descent from the abdomen in 
to the scrotum at or near the time of birth of a fetus. During development of the male 
fetus, the testes are derived from the genital ridges in the abdomen. A testis that 
remains throughout the life in the abdominal cavity is incapable of forming sperm. 
The tubular epithelium undergoes degeneration, leaving only the interstitial structures 
of the testis. 
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SEMEN ANALYSIS: 
 COLLECTION: 
               The semen specimen should be collected in a small clean wide mouthed jar 
of 10 to 20 ml (using larger jar may cause drying of some portion, when it is 
transported to the laboratory). The container must be spotlessly clean. Masturbation 
(self- stimulation) is the most preferred method. Coitus interrupts (withdrawal of 
penis just prior to ejaculation during sexual intercourse) may be used, but there is 
always a possibility of loss of the sperm rich initial portion. The container must 
be ideally warmed to the body temperature, as sperms are especially susceptible to 
cold. The slide must  be warmed,  as  otherwise motility studies  may show 
erroneous  result. Masturbation can be very stressful for some men especially 
when they know their counts are low, or if they have had problems with 
masturbation on demand for semen analysis in the past. The condition of the toilet 
room, where the patient has to go for procuring the specimen, is often related to 
their not providing the proper specimen. Men failing to provide a specimen could 
be advised either to have female partners beside or to see sexually arousing 
pictures for helping them to provide sample. They can also use a mechanical 
vibrator to  get  an erection.  
            In some cases,  additional assistance by using liquid paraffin helps in 
masturbation. The infertility centres should have a special private room to allow the 
patients for the masturbation on demand.  
             The semen samples must be collected after a sexual abstinence 3 to 5 days, 
or at least 72 hours after the last ejaculation (no sex or masturbation). It is very 
important to keep with the chosen abstinence schedule, because variations in the 
time period between ejaculations interfere with the accuracy of test results. For up 
to one week, semen characteristics, such as volume and sperm concentration, may 
increase with each day of abstinence; but after that period, the sperm motility is 
usually impaired. 
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COMPONENTS OF SEMEN ANALYSIS: 
 Sperm count 
 Motility 
 Morphology  
 Volume  
 Fructose level 
 PH 
 
SPERM COUNT: 
 
       Sperm   count,   or   sperm   concentration   to   avoid   mix-up,   measures   the 
concentration of sperm in a man's ejaculate, distinguished from total sperm count, 
which is the sperm count multiplied with volume. Anything over 15 million sperm per 
milliliter  is  considered  normal.  Anything  less  is  considered  „oligospermia‟.  The 
average sperm count today is around 60 million per milliliter in the Western world, 
having decreased by 1-2% per year from substantially higher number decades ago.  
 
MOTILITY: 
         A more specified measure is motility grade, where the motility of sperm is 
divided into four different grades: 
     Grade 4: Sperm with progressive motility. These are the strongest and swim fast 
in a straight line. Sometimes it is also denoted motility a. 
      Grade 3: (non-linear motility): These also move forward but tend to travel in 
a curved or crooked motion. Sometimes also denoted motility b. 
      Grade 2: These have non-progressive motility because they do not move 
forward despite the fact that they move their tails. 
      Grade 1: These are immotile and fail to move at all. 
 
 
 
MORPHOLOGY: 
 
i. Head - The head should be oval and smooth. 
 
ii. Mid piece - the mid piece should be straight and slightly thicker than the tail. 
iii. Tail - the tail should be single, unbroken, straight and without coils. 
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VOLUME: 
 
         The volume of the sample is measured between 1.0 mL and 6.5 mL is normal; 
WHO criteria specify that any volume greater than 1.5 mL is normal. Low volume 
may indicate partial or complete blockage of the seminal vesicles, or that the man was 
born without seminal vesicles. In clinical practice, a volume of less than 1.5 mL in 
the setting of infertility and absent sperm should prompt an evaluation for obstructive 
azoospermia. 
 
FRUCTOSE LEVEL: 
 
         The normal level of fructose in the semen is at least 3 mg/ml. WHO specify a 
normal level of 13 μmol per sample. Absence of fructose may indicate a problem with 
the seminal vesicles. 
 
PH: 
 
         The normal range of pH of the sample is 7.1-8.0; WHO criteria specify normal 
as 7.2-7.8. Acidic ejaculate (lower pH value) may indicate one or both of the seminal 
vesicles are blocked. A basic ejaculate (higher pH value) may indicate an infection. A 
pH value outside of the normal range is harmful to sperm. 
 
LIQUEFACTION: 
 
            The liquefaction is the process when the gel formed by proteins from the 
seminal vesicles is broken up and the semen becomes more liquid. It normally takes 
less than 20 minutes for the sample to change from a thick gel into a liquid. An 
abnormally long liquefaction (more than 30 minutes) time may indicate an infection. 
 
TOTAL MOTILE SPERMATOZOA: 
 
          Total motile spermatozoa (TMS) or total motile sperm count (TMSC) is a 
combination  of sperm  count,  motility and  volume, measuring how many million 
sperm cells in an entire ejaculate is motile. Use of approximately 20 million grade 
3+4 sperm in ICI, and 5 million ones in IUI may be an approximate recommendation. 
 
OTHERS: 
           The sample is tested for white blood cells. A high level of white blood cells 
(over 1 million per milliliter) may indicate an infection. 
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ABNORMALITIES: 
 
i. Aspermia: absence of semen 
 
ii. Azoospermia: absence of sperm 
 
iii. Oligospermia: low number of sperm 
 
iv. Asthenozoospermia: poor sperm motility 
 
v. Teratozoospermia: sperm carry more morphological defects than usual
[60]
. 
 
 
ADVANCED SPERM FERTILITY TESTES: COMPUTER-ASSISTED SEMEN 
ANALYSIS (CASA) 
                   The  new  technologies  such  as  CASA  incorporate  the  video  systems  
to measure the types and the speed of sperm motility. Normal sperms swim faster and 
straighter than the abnormal ones. The average speed of a human sperm is roughly 48 
to 96 mm per second. CASA permits the measurement of additional motility 
parameters such a curvilinear velocity (VCL), straight-line velocity (VSL), linearity, 
and flagellar beat frequency. CASA Measures the parameters such as VCL, VSL and 
amplitude of lateral head (ALH). The quality of sperm movement is based on a 
classification system of 0 to 4, wherein 0 represents no movement and 4 represents 
excellent forward progression; for example, a semen sample with 60% motility would 
be characterized as 3+ to 4.2. 
 
QUALITY ASSESSMENT OF CASA: 
 
                    Three levels of quality assessment are generally accepted: structure, 
process and results. 
 
SPERM CLUMPING OR AGGLUTINATION: 
 
                    The sperms may clump head-to-head, tail-to-tail, or head-to-tail. In 
particular tail-to-tail agglutination of motile sperm is noteworthy and usually is 
followed up with Sperm Function. 
 
SEMEN CULTURE TEST: 
 
                  In a semen culture test, the semen sample is tested for the presence of 
bacteria. Testing the bacterial sensitivity to antibiotics is mandatory if there is any 
presence of bacteria. Whether the bacteria present in the specimen is that are 
usually seen in normal semen or those of a bacterial disease, without the evidence of 
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inflammation or infection, there is no indication for routine culture or antibiotic 
treatment in infertile men. If urine analysis is abnormal or bacterial prostatitis is 
suspected from the history or the physical examination, semen culture is certainly 
indicated. The common sexually transmitted organisms such as Chlamydia 
trachomatis, Mycoplasma hominus and Ureaplasma urealyticulum have been 
implicated in reproductive failure in animals and humans. 
 
BIOCHEMICAL TESTS: 
 
                   Biochemical  analysis  of  seminal  plasma mostly provides  insights  into  
the function of the accessory sex glands. The fructose content of semen (normal 
value -250-400 mgm or 4-28 mmol/litre) should be routinely tested. Low fructose 
content (less than120 mgm) is often due to seminal vesiculitis, androgen deficiency or 
partial ejaculatory duct obstruction. Its absence indicates complete obstruction either 
due to a congenital block at the level of ejaculatory duct or proximal to it like 
agenesis of the vas and the seminal vesicle or following acquired post-infective 
cicatrisation. Almost invariably, these conditions are associated with azoospermia or 
severe oligospermia. The epididymis is represented by glyceryphosphorylcholine 
(GPC), the seminal vesicles by fructose, and the prostate gland by zinc. 
 
IMMUNOLOGICAL TESTS: 
 
                 In  the  enzyme-linked  immune  sorbent  assay  (ELISA)  test,  the  
antisperm antibodies measuring up to 20 units/m in 32 or 64 dilutions is considered 
normal.  
 
SPERM FUNCTION TESTS: 
               The sperm function tests assess the sperm‟s ability to fertilize the ovum. 
There is a drawback that these tests are often not standardized adequately. 
 
 
SPERM VIABILITY OR SPERM SURVIVAL TEST: 
 
                The  sperm  viability  may  be  determined  by  two  methods-Eosin  Y  
stain exclusion and hypo-osmotic swelling or HOS assay. 
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BOVINE CERVICAL MUCUS TEST: 
 
              The bovine cervical mucus test is another form of testing for the ability of 
the sperms  to  penetrate and  swim  through  cervical  mucus.  These tests  to  assess 
the fertilizing potential of sperms. This in vitro functional test measures the ability of 
penetration of the sperms. The end point of this assay is penetration of the ovum and 
decondensation of sperm heads. Men with sperm of low SPA score are less likely to 
achieve a spontaneous pregnancy than those with high SPA score. 
SPERM CHROMATIN STRUCTURAL ASSAY (SCSA): 
 
              To measure the level of DNA fragmentation in the sperm is to help the 
diagnosis and treatment for male infertility. The sperm with high levels of DNA 
fragmentation have a lower probability of producing a successful pregnancy. Vitamin 
C protects the sperms from endogenous oxidative DNA damage that could affect 
sperm quality and increased risk of genetic defects, particularly in population with 
low ascorbic acid like smokers against free radical damages. 24 Studies show that a 
daily dose of 1000 mg showed statistically significant improvement of sperms. 
THE POSTCOITAL TEST (PCT): 
 
              It  is  first  performed  by  Sims,  has  traditionally  been  a  common  way  to 
determine cervical mucus/sperm interaction. This test evaluates sperm concentration 
and motility in an aspirate of cervical mucus at midcycle shortly after the couple has 
intercourse. Results of a normal PCT would show the presence of 20 or more 
spermatozoa per high-power field. An abnormal PCT results most commonly is 
secondary to inappropriate timing of coitus. Other causes include ASA, an ovulation, 
an abnormal hormonal milieu, female or male genital tract infections, poor semen 
quality, and male sexual dysfunction. 
Sperm Penetration Assay (Spa): 
 
                 The SPA was developed to measure the functional properties of sperm 
and was initially developed following the observation that, upon the removal of the 
zona pellucida of hamster ova, the species specificity of fertilization and the block to 
polyspermy are lost. In particular, heterologous penetrations between hamster ova and 
sperm from a variety of species, including humans, has been observed. Ideally, human 
ova should be used for this assay, but they are not widely available, and there are 
ethical problems associated with their use. Therefore, hamster ova have provided a 
useful model for the measurement of human sperm function. For fertilization to occur 
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in  vivo,  the  sperm  must  first  be  capacitated  and  have  undergone  the  acrosome 
reaction. The physiology of sperm capacitation is not clearly defined. In particular, it 
is not known whether capacitated sperm that have gained the ability to penetrate 
human ova have undergone the acrosome reaction, or whether this occurs as a local 
event at the time of gamete fusion. The use of SPA as a measure of potential fertility 
is based on the theory that fertile sperm samples will either penetrate most hamster 
ova or result in a significant amount of polyspermy of the penetrated ova. Infertile 
sperm samples are expected to penetrate a lower percentage of ova or result in a lesser 
degree of polyspermy. Consideration should be given to obtaining the SPA in couples 
with unexplained infertility or in couples in whom the decision is being made to 
precede with intrauterine insemination (IUI) or IVF, since lower SPA results have 
been  predictive  of  poor  success  with  IVF  and  lower  pregnancy rates  in  couples 
attempting conception through intercourse. 
 
REACTIVE OXYGEN SPECIES (ROS) ASSAY: 
 
                        For cells living under aerobic conditions, oxygen represents a 
paradox: While it is required for survival and normal function, its metabolites can be 
potentially toxic due to the generation of oxygen-free radicals. Some of these 
metabolites, called ROS, have been shown to be produced by spermatozoa and to 
generate toxic effects on sperm function. However, when produced at the right time 
and amount, these ROS can also initiate and promote normal physiologic reactions 
such as sperm hyperactivation and capacitation. In human semen, high ROS 
formation was detected in 40% of semen samples from an unselected population of 
men consulting an infertility clinic. 
 
NUTRITION: 
 
ZINC: 
 
                    Zinc is the most important nutrient mineral influencing male fertility. 
Zinc level  in  the  seminal  plasma  is  directly  related  to  sperm  motility.  Dietary  
zinc restriction  reduces  both  sperm  count  and  seminal  plasma volume.  Zinc 
levels  in seminal plasma of normal, oligospermic, asthenospermic and azoospermic 
subjects show that a linear direct relationship seems to exist between zinc in seminal 
plasma and motility of spermatozoa. Dietary restriction of zinc can affect testicular 
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function adversely.  The  serum  testosterone  concentration  and  seminal  volume  
are  most sensitive to zinc depletion in men in the reproductive period. 
VITAMIN B 12: 
 
                Vitamin B 12 deficiency also plays a role in fertility. “Intrinsic factor” is 
necessary for the proper absorption of B12 and its deficiency is one of the causes of 
secondary infertility in male. 
VITAMIN C: 
 
               Studies  have shown  the concentration  of ascorbic acid  in  seminal  
plasma directly reflects dietary intake, and lower levels of vitamin C may lead to 
infertility and increased damage to the sperm‟s genetic material.36 Fraga et al 
demonstrated this by reducing ascorbic acid intake in healthy men from 250 mg 
to 5 mg per day. Seminal plasma levels of vitamin C decreased by 50 percent, with 
a concomitant 91- percent increase in sperm with DNA damage. 
L-ARGININE: 
 
             The biochemical and physiological relevance of L-arginine lies in its role 
as the precursor in the synthesis of polyamines and testosterone. The polyamines 
putrescence and spermidine are organic components important to sperm motility. An 
arginine metabolism is a factor in normal sperm production being involved as a 
source   of   nitric   oxide   within   spermatozoa.   Nitric   oxide   (at   endogenous 
concentrations) appears to be necessary for adequate sperm motility. The endothelial 
(eNOS) and brain (b NOS) nitric oxide syntheses are abundant in normozoospermic 
samples but is low in asthenozoospermic patients. Consequently, an adequate dietary 
amount  of  Larginine  is  necessary for  normal  spermatogenesis,  especially  for  the 
sperm motility and arginine aspartate (9 g daily) has been found to be effective in 
some cases of asthenospermia. Larginine, 4 gm. daily has been shown to improve 
sperm counts in men with oligospermia. Nuts, oilseeds, flesh foods, pulses and 
legumes are common sources of L-arginine. 
VITAMIN E: 
 
               The membranes of the germ cells and spermatozoa are very sensitive to 
oxidation   because   of   their   high   content   of   PUFA   (Polyunsaturated   fatty 
acids).Vitamin E is a major lipophilic chain-breaking anti-oxidant, which protects 
tissue  PUFA  against  peroxidation,  a  property  that  is  beneficial  in  the  male 
reproductive physiology. Oral78 administration of vitamin E significantly improves 
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the in vitro function of human spermatozoa as assessed by the zona binding test. 
Vitamin E antioxidant therapy is however, dependent on the dosage or the in vitro 
concentration of the vitamin. Vitamin E in a dose of 200 IU twice daily acts an 
antioxidant and improves sperms‟ ability to impregnate. 
SELENIUM: 
 
             Men with reduced sperm motility, supplementation with selenium (100 
mcg per day for three months) significantly increased sperm motility, but it had no 
effect on sperm  count. Selenium is one of the important ingredients that is  very 
often lacking in order mean and can be found in horsetail, which has been used with 
success in ED following prostatic enlargement. 
L- Carnitine: 
 
            Sperm  motility also  increased  both  in  quantitative  and  qualitative  
manners.  In  a multicentric study, increase in the sperm motility was also observed in 
terms of both rapid linear progression and linearity index along with that the sperm 
output after oral administration of L -carnitine in patients with idiopathic 
asthenozoospermias. Two amino acids Iysine and methionine that is necessary for the 
biosynthesis of L-carnitine in the body. 
ANTIOXIDANTS: 
 
                  Polyunsaturated  fatty  acids  and  phospholipids  are  key  constituents  in  
the sperm cell membrane and are highly susceptible to oxidative damage. Sperm 
produce controlled concentrations of reactive oxygen species, such as the superoxide 
anion, hydrogen peroxide, and nitric oxide, which are needed for fertilization; 
however, high concentrations of these free radicals can directly damage sperm 
cells. Disruption of this delicate balance has been proposed as one of the possible 
etiologies of idiopathic male infertility. About some Anti-oxidants, 
                  Vitamin A alone improved sperm function and IVF rates in studies. 
 
                  Vitamin A, Vitamin E, and essential fatty acids (omega-3 fats) were                
shown to increase sperm count in another study. 
                  Folic acid and zinc may increase sperm concentration. 
 
                    The bottom line: having a healthy diet is important for male fertility.     
You should have a diet rich in a variety fruits and vegetables and take a good 
quality multivitamin daily. You may also consider taking an omega-3 supplement, if 
your intake of fish is low. 
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COENZYME Q-10: 
 
                  In sperm cells, coenzyme Q10 (CoQ10) is concentrated in the 
mitochondrial midpiece,  where  it  is  involved  in  energy  production.  It  also  
functions  as  an antioxidant, preventing lipid peroxidation of sperm membranes. 
When sperm samples from  22  asthenospermic  men  were  incubated  in  vitro  with  
50  micro  CoQ10, significant increases in motility were observed. CoQ10 (60 mg) 
was given to 17 infertile patients for a mean 103 days, and although there were no 
significant changes in standard sperm parameters, there was a significant 
improvement in fertilization rate (p<.0.05).52 In another study, 10 mg/day of 
coenzyme Q7 (an analog of CoQ10) was given to infertile men, with resulting 
increases in sperm count and motility. 
 
NORMAL VALUES - WHO CRITERIA: 
 
The WHO reference values for a normal semen analysis are defined as given below: 
      
 Volume – 1.5ml or more 
 Total sperm count - 39 million per ejaculate or more 
 Sperm concentration - 15 million per ejaculate or more 
 pH – 7.2 or higher 
 Motility - 40 % or more motile 
 32% or more with progressive motility, within 60 minutes of ejaculation 
 
Motility is graded from a to d according to WHO manual criteria, 
 a – Fast progressive. Sperms are those which swim forward fast in a straight line, 
like guided missiles 
 b – Slow progressive 
          Sperms swim forward, but either in a curved or crooked line or slowly. 
 c – Non progressive. 
           Sperms move their tails, but do not move forward. (local motility only ) 
 d– Immotile. Sperms do not move at all. 
Sperms of grade c & d are considered poor. 
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MORPHOLOGY: 
 
                 Head - The head should be oval and smooth. 
 
             Mid piece - the mid piece should be straight and slightly thicker than 
the tail. 
                             Tail - the tail should be single, unbroken,straight and without coil. 
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PREPARATION AND PROPERTIES OF TRIAL DRUG 
 
DRUG NAME           : VEERIYA VIRUTHI  CHOORANAM 
TEXT REFERENCE : REF. AATHMARATCHAMIRTHUM –PART 2 PAGE:243                                                                                                                   
    
INGREDIENTS: 
Poonaikali vithai   -  50grams  
 
Nilapannai kizhangu                -   50grams 
 
Boomichakkarai kizhangu  -  50grams
(61) 
 
STANDARD OPERATING PROCEDURE: 
Source of raw drugs: 
            The required raw drugs are procured from a wall reputed indigenous drug 
shop. The raw drug will be authenticated by the botanist, Dept. of Medicinal Botany, 
Govt. Siddha Medical College, Arumbakkam, Chennai – 106. 
Purification of raw drugs: 
Raw drugs are purified as mentioned in Sikitcha Ratna Deepam Sarakku 
Suthi Muraigal. 
Preparation: 
            The ingredients of trial drug should be powdered individually  and  strained 
using a fine cloth and the  mixed in equal ratio then bottled up. 
Drug Storage: 
The trial drug is stored in clean dry air tight container and it is dispensed 
to the patients in packets. 
Dose: 
                   1 gm., twice a day with cow‟s milk after meals. 
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POONAIKAALI VITHAI 
 
  BOTANICAL NAME  -Mucuna pruriens  
  SUVAI     - THUVARPPU 
  THANMAI     - THATPAM 
   PIRIVU     - INIPPU 
  ACTION     - ASTRINGENT, APHRODISIAC, NERVINE    TONIC  
                                                                                                                                                             
GUNAM: 
                                                                                
 தழுதள஭஥ாற் ஫த்ததாடு சாரிபத்தப் த஧ாக்கும்                
஧ழுதுபுரி கின்஫கபப் ஧ானும் – அழுததகுந் 
தூ஬நிளச யிந்துவுநாஞ் சாற்஫ற் கரும்பூள஦க் 
கா஬ி யிளதளனக் கமறு(62)                                                                                                                                                                            
                                                          - குண஧ாடம் – ப௄஬ிளக யகுப்பு  ஧க்கம் எண் : 707  
 
 NILAPPANAI KIZHANGU 
 
BOTANICAL NAME            -Curculigo orchioides 
SUVAI             - INIPPU 
THANMAI                        - THATPAM 
PIRIVU             - INIPPU 
ACTION                        - TONIC, CARMINATIVE, ASTRINGENT   
              
 
 GUNAM:  
 
தநகய஦ல் தணிப௅ம் வயண்குட்டந் தான்யி஬கும் 
த஧ாக நிகவுப௃றும் வ஧ாற்வகாடிதன! – த஧ாகாத 
சூள஬தந கங்கத஭ாடு துன்னுகரும் புள்஭ிப௅ம்த஧ாஞ் 
சா஬ ஥ி஬ப்஧ள஦க்குந் தான். (63) 
               -குண஧ாடம் – ப௄஬ிளக யகுப்பு   ஧க்கம் எண் : 576 
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 BOOMI CHAKKARAI KIZHANGU 
 
 
BOTANICAL NAME       - Maerua oblongifolia( Forssk) A.Rich 
SUVAI         - INIPPU 
THANMAI                    - THATPAM 
PIRIVU                    - INIPPU 
ACTION                    - APHRODISIAC,LAXATIVE,TONIC.
(64) 
 
 
 
 
GUNAM :  
 
 
NkfKW Ks;SUf;F ntl;il adw;wzpAk; 
NghFNk %yk; Gfyf;Nfs; - ghFnkhopg; 
Nghd;didaha; G+kpr; rUf;fiuf; fpoq;Ff;F 
Td;dTly; gUf;Fk; tho;j;J(65) 
                       -gjhHj;j Fzghlk; -pg no :183 
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MATERIALS AND METHODS 
 
STUDY DESIGN: 
 
                    A Clinical study on AAN MALADU was conducted at the OPD section 
of Post Graduate, Pothu Maruthuvam Department attached to Arignar Anna Hospital 
Of Indian Medicine, Chennai-106, during the period of 2015 – 2017. The study was 
approved by Institutional Ethical Committee(IEC) and the approval number is 
GSMC-CH-ME-4/2015/007. it was registered in clinical trials registry-india(ctri) and 
the register number is CTRI/2017/05/008448 
POPULATION AND SAMPLE: 
 
                    The population consists of all patients who were attending the OPD 
section of Post Graduate, Pothu Maruthuvam Department attached to Arignar Anna 
Hospital Of Indian Medicine, Chennai.-106 sample consists of Aan maladu who 
satisfying the inclusion and exclusion criteria mentioned below. 
 
SAMPLE SIZE: 
 
        The trial size will be 20 patients. 
      
 
INCLUSION CRITERIA: 
 
    Age 21-45 years 
 
    Oligospermia (low number of sperm <15 millions) 
 
    Oligo asthenospermia 
 
    Willing to give semen for the investigation 
 
 
EXCLUSION CRITERIA: 
 
    Azoospermia 
 
    Teratospermia 
 
    Hydrocele 
 
    Varicocele 
 
    Diabetes mellitus 
 
    Hypertension 
 
    Cardiac disease 
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WITHDRAWAL CRITERIA: 
 
    Intolerance to the development of adverse reactions during the drug trial (If ADR is  
 
       reported the patient will be directed to RPC). 
 
    Patients turned unwilling to continue in the course of clinical trial. 
 
    Any other acute illness. 
         
        DURATION OF TREATMENT: 
 
 
            48 days. 
 
 
EVALUATION OF CLINICAL PARAMETERS: 
 
                  The  history  includes  past,  personal,  family,  occupation,  dietary  
habits, seasonal history and associated history. 
 
Clinical investigation: 
 
Blood: 
 
                TC,DC,ESR,Hb,VDRL,Sugar,Urea,Serum,Creatinine,Cholesterol 
 
Urine: 
 
                 Albumin, Sugar, Deposit 
 
SEMEN ANALYSIS 
 
    The volume, colour, appearance of the SEMEN sample 
    Approximate number of total SPERM CELLS 
    SPERM MOTILITY/ FORWARD PROGRESSION 
    Percentage of sperm with NORMAL MORPHOLOGY & MOTILITY 
    VISCOSITY of semen 
    pH of the Seminal fluid 
    Liquification time 
    Antisperm antibody 
 
SIDDHA ASSESSMENT: 
 
 
    Envagai Thervugal 
 
    Neerkuri 
 
    Neikkuri 
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                      A case sheet format was prepared on the basis of the Siddha 
methodology example   envagai   thervugal,   mukkutram,   nilam,   kaalam,   udal   
thathugal, including  neerkuri  and  neikuri.  Individual  case sheet  was maintained  
for  each patient at outpatient department. 
 
Data collection forms: 
 
Required information will be collected from each patient by using following forms. 
 
Form I             : Screening and selection proforma 
 
Form II            : History taking proforma 
 
Form III          : Clinical assessment proforma 
 
Form IV          : Clinical assessment during and after trial 
 
Form V           :  Laboratory Investigation proforma 
 
Form VI          :  Informed consent 
 
Form VII        : Withdrawal form 
 
Form VIII       : Patient information sheet 
 
Form IX          : Diet sheet 
 
Data Analysis: 
 
                  After enrolling the patients in the study a separate file for each patient 
will be maintained and all forms will be kept in the file. Whenever the patient visits 
OPD during the study period necessary entries will be made in the assessment forms. 
The data entries and adverse events if any will be monitored by the Head of 
the Department. 
 
Outcome of Treatment 
 
                  The outcome treatment is mainly assessed to improve the sperm count at 
least 20% and by comparing the reduction in clinical symptoms and recurrence 
before and after treatment and assessed by comparing the safety parameters 
before and after treatment. 
 
Adverse effect and Serious effect Management: 
 
                   If the trial patient develops any adverse reactions the patient will be 
referred to the Pharmacovigilance department of SCRI and documented.  For 
any adverse effect the investigator will give the proper management in the OPD. 
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Ethical issues 
 
1. Informed consent will be obtained from the patient after explaining about the      
clinical trial in an understandable language. 
2. After the consent of the patient (through consent) if they fit in the criteria they 
will be enrolled in the study. 
3. Treatment will be provided free of cost. 
4. Concomitant medicines will be used if there is any need. 
5. The patients who are excluded (as per the exclusion criteria) will be referring to 
OPD.  
 
            Analysis of Trial medicine: 
 
1. The acute and sub-acute toxicity study was carried out in centre for laboratory 
animal technology and research ,Sathyabama university,kelambakkam, Chennai-119 . 
2. The Pharmacological analysis of trial drug for its Spermatogenic activity was       
carried out in centre for laboratory animal technology and research ,Sathyabama 
university,kelambakkam, Chennai-119 . 
3. The  physiochemical  analysis  was  performed  in  Siddha  Central Research 
Institute, Chennai.       
 
4.  Observation made from patients with sign and symptoms of the disease and 
their prognosis were recorded. 
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RESULTS AND OBSERVATION 
 
The study on Aan maladu was carried out in 20 patients in the Department of 
Pothu Maruthuvam, Government Siddha Medical College, Chennai-106 attached to 
Arignar Anna Hospital during 2015-2017 were analyses. The observation were made 
and tabulated with following criteria. 
 
 
 Age Distribution 
 Kaalam 
 Thinai  
 Occupational status 
 Socio economic status 
 Food habits  
 Personal habits 
 Symptoms 
 Mukkutram- Vaatham, Pitham, Iyyam 
 Ezhu Udal Kattugal 
 Envagai Thervugal 
 Naadi 
 Neikuri 
 Clinical Progress 
 Grading of Results   
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           AGE DISTRIBUTION: 
 
 
 
 
 
 
 
 
 
Inference: 
According to the above mentioned data 40% of patients were in age group 21-
30 years, 55% of patients were in age group 31-40 years and 5% of patients were in 
age group 41-50 years. 
 
 
 
0%
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40%
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21-30 31-40 41-50
40% 
55% 
5% 
AGE DISTRIBUTION 
PERCENTAGE
Sl.No        Age No. of Patients / 20       Percentage 
1.       21-30 8 40% 
2.       31-40 11 55% 
3.       41-50 1 5% 
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THINAI: 
Sl. No            Thinai No. of Patients/20       Percentage 
1 Kurinji 0  0% 
2 Mullai 0 0% 
3 Marutham 6 30% 
4 Neithal 14 70% 
5 Paalai 0 0% 
 
 
 
Inference: 
According to the above mentioned data 70% of patients were from Neithal, 
and 30% of patients were from Marutham. 
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PARUVA KAALAM: 
 Sl. No Paruva Kaalam            Months    No. Of   
Patients/20 
  Percentage 
      1.   Kaar kaalam    Avani, puratasi 
Mid Aug- Mid Oct 
         2        10% 
      2. Koothir kaalam  Iyppasi, Kaarthigai 
Mid Oct- Mid Dec 
         4        20% 
      3. Munpanikaalam    Margazhi, Thai 
Mid Dec- Mid Feb 
         8        40% 
      4. Pinpani kaalam     Maasi, Panguni 
Mid Feb- Mid April 
         5         25% 
      5. Elavenil kaalam   Chithirai, Vaigasi 
Mid April- Mid June 
         0          0% 
       6.   Mudhuvenil     
       kaalam 
      Aani, Aadi 
Mid June- Mid Aug 
          1            5% 
 
 
 
Inference: 
40% of cases came in Munpani  kaalam, 25% of cases in Pinpani kaalam, 20% 
of cases came in  Koothir kaalam, 10% of cases came in Kaarkaalam and 5% cases in 
Mudhuvenil kaalam 
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              OCCUPATIONAL STATUS: 
Sl. No Occupational Status No. of  Patients/20       Percentage 
1. Drivers 7 35% 
2. Labourers 6 30% 
3. IT Profession 5 25% 
4. Businessman 2 10% 
 
 
 
Inference: 
35% of cases were Drivers, 30% of cases were Labourers, 25% of cases were 
IT Profession and 10% of cases were Businessman. 
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SOCIO ECONOMIC STATUS: 
Sl. No Socio Economic Status No. of  Patients/20       Percentage 
1. Low income group 
(upto 2,00,000/ annum) 
10 50% 
2. Middle income group 
(2,00,000- 5,00,000/ 
annum) 
6 30% 
3. High income group 
(above 5,00,000/ annum) 
4 20% 
 
 
Inference: 
50% of patients belong to low income group, 30% of patients belongs to 
middle income group and 20% of patients belongs to high income group.  
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FOOD HABITS: 
Sl. No       Food Habits  No. of Patients/20 Percentage 
1. Vegetarian Diet 6     30% 
2.       Mixed Diet 
(including non-veg) 
14      70% 
 
 
Inference: 
70% of patients were mixed diet (including non-vegetarian) 
30% of patients were vegetarian. 
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PERSONAL HABITS: 
Sl. No Personal 
Habits 
No. of  
Patients/20 
Percentage 
1. Smoker 6 30% 
2. Alcoholic 5 25% 
3. Tobacco 
chewing 
0 0% 
4. No other habits 9 45% 
 
 
 
Inference: 
30% of cases were smokers 
25% of cases were alcoholic  
And 45% of cases were having No other above habits. 
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SYMPTOMS: 
Sl. No Symptoms  No. of Patients/20        Percentage  
1. Premature 
Ejaculation 
12 60% 
2. Erectile 
Dysfunction 
8 40% 
3. Nocturnal 
Emission 
9 45% 
4. No related 
Symptoms 
4 20% 
 
 
 
Inference: 
60% of cases came with complaints of Premature Ejaculation, 40% of cases 
came with complaints of Erectile Dysfunction, and 45% of cases came with 
complaints of Nocturnal Emission 20% of cases had No  related Symptoms 
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VAATHAM: 
Sl. No   Vaatham   No. of Patients/20       Percentage 
1.     Pranan    0 0% 
2.     Abanan   20 100% 
3.     Vyanan    8 40% 
4.     Udhanan    0 0% 
5.     Samanan    0 0% 
6.      Nagan    0 0% 
7.     Koorman    3 15% 
8.     Kirukaran    0 0% 
9.    Devathathan    12 60% 
10.    Dhananjeyan    0             0% 
 
 
Inference: 
Abanan was affected in 100% of patients, koorman was affected in 15% of 
patients , vyanan was affected in 40% of patients and devathathan was affected in 
60% of patients. 
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PITHAM: 
   Sl. No        Pitham    No. of Patients/20 Percentage 
       1.     Anal Pitham     6         30% 
       2.   Ranjaga Pitham     0         0% 
       3. 
  Sadhaga 
Pitham 
    20        100% 
       4. Aalosaga Pitham     3         15% 
       5.   Prasaga Pitham     0         0% 
 
Inference: 
Anar pitham was affected in 30% of patients, sadhaga pitham was affected in 
100% of patients and Aalosaga Pitham was affected in 15% of patients.  
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IYYAM: 
  Sl. No Iyyam       No. of Patients/20 Percentage 
      1.     Avalambagam          0         0% 
      2.       Kilethagam          0         0% 
      3.       Bothagam          0         0% 
     4.        Tharpagam          3         15% 
     5.        Sandhigam          4         20% 
 
 
 
Inference: 
  Tharpagam was affected in 15% of patients and Sandhigam was affected in 20% of 
patients. 
 
 
 
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
0% 
0% 
0% 
15% 
20% 
IYYAM 
AVALAMBAGAM
KILETHAGAM
BOTHAGAM
THARPAGAM
SANDHIGAM
                                                                                RESULTS AND OBSERVATION 
 
Veeriya viruthi Chooranam for Aan Maladu  Page 81 
 
UDAL KATTUGAL: 
       Sl. No    Udal Kattugal         No. of     
    Patients/20   
Percentage 
1.          Saaram 20       100% 
2.          Senner  0          0% 
3. Oon  0          0% 
4.         Kozhuppu  0          0% 
5. Enbu  4         20% 
6.            Moolai  0           0% 
7.           Sukkilam 20         100% 
 
 
Inference: 
 Saaram and Sukkilam were affected in 100% of patients and Enbu was affected in 
20% of patients. 
 
 
Series 1
0%
20%
40%
60%
80%
100%
100% 
0% 0% 0% 
20% 
0% 
100% 
UDAL KATTUGAL 
SAARAM
SENNEER
OON
KOZHUPPU
ENBU
MOOLAI
SUKKILAM
                                                                                RESULTS AND OBSERVATION 
 
Veeriya viruthi Chooranam for Aan Maladu  Page 82 
 
ENN VAGAI THERVU: 
       Sl. No        Enn Vagai     
           Thervu 
No. of Patients/20               Percentage 
1. Naa 0           0% 
2. Niram 0           0% 
3. Mozhi 0           0% 
4. Vizhi 3          15% 
5. Naadi            20         100% 
6. Sparisam 0           0% 
7. Malam 0           0% 
8. Moothiram 0           0% 
 
 
Inference: 
Naadi was affected in 100% of patients and Vizhi was affected in 15% of  
patients. 
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NAADI: 
   Sl. No Naadi  No. of Patients/20 Percentage 
       1.      Vaathapitham 9 45% 
       2.       Pithavaatham 11 55% 
 
 
 
 
Inference: 
45% of patient’s Vaathapitham Naadi was felt and 55% of patient’s Pithavaatham 
Naadi was felt. 
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NEIKKURI: 
 
   Sl. No 
 
Neikkuri 
 
 
     No. of Patients /20 
 
            Percentage 
        
      1. 
Vali 
   (spreads like snake) 
      
      8 
      
     40% 
       
      2. 
            Azhal 
      (spreads like ring) 
      
      12 
       
      60% 
       
      3. 
Iyyam 
    (spreads like pearl) 
      
       0 
                    
                    0% 
 
 
 
Inference: 
40% of cases show Vali Neikkuri and 60% of cases show Azhal Neikkuri 
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CLINICAL PROGRESS: 
 Sl. No Symptoms   No. of  Patients/20          Percentage 
     BT      AT    BT     AT 
     1.     Premature Ejaculation       12       4    60%    20% 
     2.       Erectile Dysfunction        8       2    40%    10% 
      3.        Nocturnal Emission        9       3    45%    15% 
 
 
 
Inference: 
 Before treatment 60% of cases had Premature Ejaculation, 40% of cases had Erectile 
Dysfunction and 45% of cases had Nocturnal Emission. 
 After treatment Premature Ejaculation having 20% of cases, Erectile Dysfunction 
having 10% cases and Nocturnal Emission having 15% cases . 
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SEMEN ANALYSIS BEFORE AND AFTER TREATMENT 
   
 
S.No 
      Sperm count 
     Million/ cu mm 
 
  No. of patients / 20 
 
        Percentage 
    BT       AT   BT       AT 
  1. 1-10 million/cumm       4         1   20%       5% 
  2. 11-20 million/cumm       9         0   45%       0% 
  3. 21-30 million/cumm       5         4   25%      20% 
  4. 31-40 million/cumm     NIL         2   NIL      10% 
  5. 41-50 million/cumm       2         7   10%       35% 
  6. 51-60 million/cumm     NIL         5   NIL       25% 
  7. 61-70 million/cumm     NIL         1   NIL        5% 
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Inference: 
Before treatment: 
 20% of cases sperm count had 1 -10 million/cumm, 45% of cases sperm count had        
11 – 20 million/cumm, 25 % of cases sperm count had 21 – 30 million/cumm, 10% of 
cases sperm count had 41-50 million/cumm. 
After treatment: 
 5%  of cases sperm count had 1-10 million/cumm,  20% of cases sperm count had 21 -
30 million/cumm, 10% of cases sperm count had 31-40 million/cumm, 35% of cases 
sperm count had 41-50 million/cumm, 25% of cases sperm count had 51- 60 
million/cumm, 5% of cases sperm count had 61-70 million/cumm. 
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GRADATION OF RESULTS 
 
 
 
Inference : 
 55% of patients show good result, 30% of patients show moderate result and 
15% of patients show poor result. 
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BEFORE TREATMENT 
 
 
 
S.No. 
 
OP.No. 
 
Age 
HEMATOLOGICAL REPORT URINE ANALYSIS  STOOL EXAMINATION 
Tc 
Cu/mm 
Dc ESR Hb 
(Gm.) 
 
Alb 
 
Sug 
 
Dep 
 
  Ova 
 
 Cyst 
P L E 1/2hr 1 hr. 
1. 8921 35 9400 58 39 3 5 12 12.4 Nil Nil OPC Nil Nil 
2. 8894 38 9800 55 42 3 5 22 12.2 Nil Nil OPC Nil Nil 
3. 1978 29 9600 58 36 6 7 13 12.4 Nil Nil OPC Nil Nil 
4.    601 28 9000 60 32 8 6 12 12.6 Nil Nil OPC Nil Nil 
5. 3458 34 9700 54 42 4 10 22 14 Nil Nil OPC Nil Nil 
6.   8566 37 10700 66 30 4 2 3 14 Nil Nil OPC Nil Nil 
7. 3805 35 9300 57 38 5 10 20 13.8 Nil Nil OPC Nil Nil 
8. 4567 27 9400 56 39 5 12 24 13 Nil Nil FPC Nil Nil 
9. 7467 30 9400 58 39 3 10 22 12.4 Nil Nil OEC Nil Nil 
10. 9485 40 9400 58 36 6 2 5 13 Nil Nil OPC Nil Nil 
11. 4564 38 9600 55 42 3 2 5 14 Nil Nil Nil Nil Nil 
12. 8740   30 9600 59 37 4 7 12 13 Nil Nil OPC Nil Nil 
13.   3806 30 9000 59 35 6 6 10 14.6 Nil Nil FPC Nil Nil 
14. 7265 29 10100 59 37 4 15 25 13.2 Nil Nil OEC Nil Nil 
15. 7932 25 9000   58 38 4 2 4 14.8 Nil Nil FPC Nil Nil 
16. 4099 36 9200 56 38 6 5 10 12.4 Nil Nil OPC Nil Nil 
17. 4100 39 10700 62 31 7 15 20 15 Nil Nil OPC Nil Nil 
18. 3007 40 9700 58 37 5 10 18 12.5 Nil Nil OPC Nil Nil 
19. 7386 42 10600 62 34 4 7 17 14 Nil Nil OPC Nil Nil 
20. 6784 35 9400 57 38 5 3 5 12.8 Nil Nil Nil Nil Nil 
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AFTER TREATMENT 
 
 
S.No. 
 
OP.No. 
 
Age 
HEMATOLOGICAL REPORT URINE ANALYSIS  STOOL EXAMINATION 
Tc 
Cu/mm 
Dc ESR Hb 
(Gm.) 
 
Alb 
 
Sug 
 
Dep 
 
 Ova 
 
  Cyst 
P L E 1/2hr 1 hr. 
1. 8921 35 9450 56 42 2 4 8 12 Nil Nil Nil Nil Nil 
2. 8894 38 9750 54 42 4 4 10 12.5 Nil Nil Nil Nil Nil 
3. 1978 29 9600 60 35 5 13 6 13 Nil Nil Nil Nil Nil 
4.    601 28 8800 62 32 6 5 10 12.7 Nil Nil Nil Nil Nil 
5. 3458 34 9600 58 40 2 8 18 13.8 Nil Nil OPC Nil Nil 
6.   8566 37 10800 65 30 5 4 6 14 Nil Nil Nil Nil Nil 
7. 3805 35 9400 60 35 5 9 18 13.7 Nil Nil FPC Nil Nil 
8. 4567 27 9600 58 36 6 24 10 13 Nil Nil Nil Nil Nil 
9. 7467 30 9000 60 38 2 9 18 12.5 Nil Nil Nil Nil Nil 
10. 9485 40 9200 60 34 6 4 10 12.8 Nil Nil OPC Nil Nil 
11. 4564 38 9700 58 40 2 3 6 14.2 Nil Nil Nil Nil Nil 
12. 8740   30 9550 60 35 5 10 14 12.8 Nil Nil Nil Nil Nil 
13.   3806 30 9100 58 37 5 5 12 14.5 Nil Nil Nil Nil Nil 
14. 7265 29 10300 60 36 4 10 13 13 Nil Nil Nil Nil Nil 
15. 7932 25 9200 58 38 4 3 6 15 Nil Nil Nil Nil Nil 
16. 4099 36 9350 55 42 3 8 16 12.7 Nil Nil Nil Nil Nil 
17. 4100 39 10500 60 34 6 12 18 14.5 Nil Nil Nil Nil Nil 
18. 3007 40 9700 58 38 4 15 20 12.4 Nil Nil FPC Nil Nil 
19. 7386 42 10450 55 40 5 8 16 14.5 Nil Nil OPC Nil Nil 
20. 6784 35   9600 60 36 4 3 8 13.1 Nil Nil Nil Nil Nil 
 
 
TC- Total Count, DC- Differential Count, P- Polymorph, L- Lymphocytes, E- Eosinophil, HB- Haemoglobin, ESR- Erythrocytes Sedimentation Rate, Alb- 
Albumin, Sug- Sugar, Dep- Deposits, OPC- Occasional Pus Cells, OEC- Occasional Epithelial Cells, FPC- Few Pus Cells 
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NO. OF OP PATIENTS BEFORE TREATMENT AND AFTER TREATMENT 
 
 
 
SL. 
NO. 
OP.NO. AGE SEMEN ANALYSIS 
BEFORE TREATMENT 
SEMEN ANALYSIS 
AFTER TREATMENT 
TOTAL NO. 
OF DAYS 
RESULT 
1. 8921 35 TSC – 22million/cu mm 
AM-18 % 
TSC – 50million/cu mm 
AM- 58% 
48 Days Good Improvement 
2. 8894 38 TSC –13 million/cu mm 
AM- 8% 
TSC – 30million/cu mm 
AM- 32% 
48 Days Moderate improvement 
3. 1978 29 TSC – 25million/cu mm 
AM-18 % 
TSC – 58 million/cu mm 
AM-56 % 
48 Days Good  Improvement 
4.    601 28 TSC –12 million/cu mm 
AM-24 % 
TSC –55 million/cu mm 
AM- 60% 
48 Days Good  Improvement 
5. 3458 34 TSC –22 million/cu mm 
AM-10 % 
TSC – 24million/cu mm 
AM-22 % 
48 Days Poor  Improvement 
6.   8566 37 TSC –19 million/cu mm 
AM- 20% 
TSC – 60million/cu mm 
AM- 55% 
48 Days Good  Improvement 
7. 3805 35 TSC –42 million/cu mm 
AM-10 % 
TSC – 60million/cu mm 
AM- 35% 
48 Days Moderate  Improvement 
8. 4567 27 TSC –15 million/cu mm 
AM- 18% 
TSC – 48million/cu mm 
AM- 65% 
48 Days Good  Improvement 
9. 7467 30 TSC – 21million/cu mm 
AM- 8% 
TSC –40 million/cu mm 
AM- 40% 
48 Days Moderate  Improvement 
10. 9485 40 TSC –45 million/cu mm 
AM-15  % 
TSC –48 million/cu mm 
AM-25 % 
48 Days Poor  Improvement 
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SL. 
NO. 
OP.NO. AGE SEMEN ANALYSIS 
BEFORE TREATMENT 
SEMEN ANALYSIS 
AFTER TREATMENT 
TOTAL NO. 
OF DAYS 
RESULT 
11. 4564 38 TSC – 18million/cu mm 
AM-10 % 
TSC – 50million/cu mm 
AM- 55% 
48 Days Good Improvement 
12. 8740   30 TSC –9 million/cu mm 
AM- 15%
**
 
TSC – 52million/cu mm 
AM- 55% 
48 Days Good  Improvement 
13.   3806 30 TSC – 16million/cu mm 
AM-12 % 
TSC – 48 million/cu mm 
AM-53 % 
48 Days Good  Improvement 
14. 7265 29 TSC –15 million/cu mm 
AM-15 % 
TSC –45 million/cu mm 
AM- 58% 
48 Days Good  Improvement 
15. 7932 25 TSC –8 million/cu mm 
AM-22 %
**
 
TSC – 50million/cu mm 
AM-62 % 
48 Days Good Improvement 
16. 4099 36 TSC –14 million/cu mm 
AM- 15% 
TSC – 67million/cu mm 
AM- 60% 
48 Days Good  Improvement 
17. 4100 39 TSC –10 million/cu mm 
AM-13 % 
TSC – 25million/cu mm 
AM- 55% 
48 Days Moderate   Improvement 
18. 3007 40 TSC –23 million/cu mm 
AM- 15% 
TSC – 38million/cu mm 
AM- 45% 
48 Days Moderate  Improvement 
19. 7386 42 TSC – 3million/cu mm 
AM- 7% 
TSC –5 million/cu mm 
AM- 15% 
48 Days Poor   Improvement 
20. 6784 35 TSC –15 million/cu mm 
AM-17  % 
TSC –30 million/cu mm 
AM-40 % 
48 Days Moderate  Improvement 
 
 
BEFORE TREATMENT 
 
 
 
 
AFTER TREATMENT 
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                                                          DISCUSSION 
 
           One of the Predominant disorders that endanger human species is 
INFERTILITY in  Both  men  and  women.  The  incidence  of  infertility  is 
comparatively higher in males became of the drastic changes in human life style 
– irregular food habits, high calorie food items, fast food behavioral changes. 
Environmental toxins and changed compounds used for dispensing various ailments. 
It has been suggested that the average sperm count has been decreasing over the past 
50 years. 
           Aan maladu as stated in Yugi Vaidya Chindhamani has close resemblance 
with male infertility in modern system. 
           In my study 20 patients were treated in outpatient department of Post 
Graduate Pothumaruthuvam Department, Govt. Aringar Anna Hospital attached with 
Govt. Siddha Medical College, Chennai – 106. 
           All patients were subjected to preliminary investigations which include 
hematological, urine examination, Semen Analysis before and after Treatment. 
            The Trial  Medicine  VEERIYA VIRUTHI CHOORANAM was administered  
48 days. 
             Veeriya viruthi Chooranam was justified for Aan Maladu through various 
process Drug Authentication, Toxicity study, Pharmacological Activity, Biochemical 
Analysis, Physico chemical Analysis, , Clinical study and Biostatistical analysis. 
DRUG AUTHETICATION: 
          Herbal drugs  like Mucuna pruriens, Curculigo orchioides, Maerua 
oblongifolia were procured from a well reputed indigenous drug shop and 
authenticated by  the Botanist, Dept.of Medicinal Botany, Govt. Siddha Medical 
College, Arumbakkam, Chennai – 106. 
 
PRE CLINICAL SCREENINGS: 
PHSICOCHEMICAL ANALYSIS: 
              Loss on Drying(at 105
0
C) was 2.235%, The total ash value of  veeriya viruthi 
chooranam was 6.02%, The water soluble ash value was 1.56% The acid soluble ash 
value was 1.01%, The water soluble extractive was 19.55%, alcohol soluble extractive 
was 14.40%,  pH value was 5.61%. 
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TOXICITY STUDY: 
IAEC: 
                  I got IAEC approval for toxicological and pharmacological studies  at 
Sathyabama University ,Chennai. IAEC NO: SU/CLATR/IEAC/VII/048/2016 
ACUTE TOXICITY: 
               Acute and sub acute toxicity studies were conducted on experimental rats at 
Sathyabama University, Chennai, Tamilnadu. 
               Acute toxicity study of the drug Veeriya Viruthi Chooranam with cow’s 
milk  was carried out as the OECD guideline -  423 (Organisation for Economic Co-
operation and Development). 
                The acute toxicity study of  Veeriya viruthi Chooranam was studied and the 
drug was proved safer for long term administration, as it did not exhibit any 
significant toxicity at 2000 mg / kg body weight.  
SUB ACUTE TOXICITY: 
              Sub acute toxicity study as per the OECD guideline of – 407. Under the 
dosage of trial drug 200mg / kg (Low dose), 400mg / kg (High dose) it did not exhibit 
any significant.  
HISTO PATHOLOGY: 
             At the end of toxicity studies the animal were sacrificed and they were 
subjected to hematological parameters (TC, DC & Hb) chemical parameters ( LFT, 
RFT) and histopathology of vital organs like Liver, Kidney, Spleen, Lungs were 
carried out. The studied did not exhibit the evidence of remarkable pathological 
lesions in the tissues. 
PHARMACOLOGICAL ACTIVITY: 
                     The spermatogenic activity of Veeriya viruthi Chooranam   was carried 
out in wistar rats through Gentamicin-Induced testicular toxicity method. Then trial 
drug was administrated shows a potent spermatogenic activity during the studies. The 
pharmacology studies of trial medicine Veeriya viruthi Chooranam showed 
significant spermatogenic Activity in wistar rats. 
                  The result of preclinical screening, the result of chemical analysis, 
Toxicological studies, Pharmacological studies were shown in annexures. 
BIOCHEMICAL ANALYSIS: 
                  Veeriya viruthi Chooranam contains iron, sulphide, calcium, Phosphate 
and reducing sugar. 
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IEC AND CTRI: 
Study Design 
           The study was approved by Institutional Ethics Committee ( IEC ) and the 
approval number is GSMC-CH-ME-4/2015/007.It was registered in Clinical Trials 
Registry – India ( CTRI ) and the reference number is CTRI/2017/05/008448 
Population and sample : 
          The population consists of all patients satisfying the inclusion and exclusion 
criteria mentioned below. Sample consists of 20 AAN MALADU patients who were 
attending the OPD of Arignar Anna Hospital, Arumbakkam, Chennai – 106. 
CLINICAL STUDY: 
          All the necessary investigation were carried out to all patients and Veeriya 
viruthi Chooranam were given. Weekly once follow up were done. Total duration of 
treatment ranges from 48 days. All the patients were strictly advised to follow diet 
restriction and peaceful life style to normalize the immune mechanism. 
Age Distribution: 
 
            According to this study age distribution was 40% of patients were in age 
group 21-30  years, 55% of patients were in age group 31-40  years and 5% of 
patients were in age group 41-50 years. 
          High incidences of cases were noted in age ranging of 31 – 40 years during the 
studies 
 
Distribution of Thinai: 
 
           According to this study 70% of the Patients came from Neithal because 
Chennai and surrounding areas come under Neithal thinai, and 30% of patients 
were from Marutham. 
Paruva kalam: 
 
 
             According to this study 40% of cases came in Munpani  kaalam, 25% of cases 
in Pinpani kaalam, 20% of cases came in  Koothir kaalam, 10% of cases came in 
Kaarkaalam and 5% cases in Mudhuvenil kaalam. Seasonal incidence is not affected 
their disease, male infertility. 
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Occupational Status: 
 
              35%of the patients were Drivers, 30% of patients were working as Labourers, 
10% of patients are Businessman, and 25% of patients are IT Profession. Drivers and 
IT people mostly affected as they are having sleeplessness, stressful and night based 
work . 
Socio Economic Status: 
 
              The majority of the Patients affected are from poor socio economic status.  
Poor hygienic conditions expose to  polluted  atmosphere and  lower immune 
response made them prone to the disease. 
Food Habits: 
 
              30% Patients were pure vegetarian, 70% were Mixed Diet (including non-
vegetarian). Though a non-vegetarian diet account is not a reason for the occurrence 
of male infertility. 
Personal Habits: 
 
               In my study 25% of the Patients were using alcohol, 30%were smoker, 
and 45% were having others. The observation coincides with the conception that 
male infertility the disease may be due to smoking, Alcohol consumption.  
Classification of Results According To Vali, Azhal and Iyyam:- 
Vali: 
  Spermatogenesis, Premature Ejaculation, Nocturnal Emission is due to 
deranged  Abana Vayu. 
  Erectile dysfunction is due to deranged viyanan. 
  In 100% patients abanan was affected, viyanan was affected 40% of patients. 
  Koorman affected in 15% of cases. 
 Devathathan affected in 60% of cases, Affected Devathathan  produced insomnia, 
tiredness. 
 
Azhal: 
                 Sadhaga Pitham was affected in 100% of Patients, Aalosaga Pitham was 
affected in 15% of patients and Anal Pitham was affected in 30% of patients. 
                 Affected analagam produced loss of appetite. 
                 All the cases were unable to carryout regular works properly. Sathagam 
indicates this one. So 100% were affected in Sathaga pitham. 
                 Affected Alosagam produced impairment of eye sight. 
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Iyyam: 
 
                 15% of patients Tharpagam were affected. 20 % of Patients santhigam 
was affected. 
                 Affected Tharpagam produced impairment of eye sight. 
                 Santhigam iyam gives stability, lubrication and movements of joints. 
 
                 Affected Santhigam produced joint pain. 
 
Udal Kattugal: 
 
                   Both bodily and mental weakness arises when saaram was affected. In 
100% of patients both the saaram and sukkilam were affected. In 20% of cases enbu 
was affected. 
Envagai Thervu 
 
Naadi was affected in 100% of patients and 15% of patients vizhi was 
affected. 
Naadi 
 
            In 45% of patients Vaathapitha Naadi was felt and 55% of patients 
Pithavaatha  Naadi were felt. 
According to Sathaganadi, 
 
 (nghUshd thjj;jpy; gpj;jQ; Nrh;e;J 
.......................................jhJel;lk;,) 
  
(Rpwg;ghd gpj;jj;jpy; thj ehb  
NrhpYW jhJel;l Kju gPil……………..) 
 
Neikuri 
 
             60% of cases show azhal neikuri (spreads like ring) and 40% of cases 
Show vali neikuri (spreads like snake). 
Clinical Progress: 
 
                  Before treatment 60% of cases had Premature Ejaculation, 40% of cases 
had Erectile Dysfunction and 45% of cases had Nocturnal Emission. After   treatment   
Premature   Ejaculation   having   20%   of   cases, Erectile Dysfunction having 10% 
cases and Nocturnal Emission having 15% cases . 
Trial Medicine: 
 
All the 20 patients treated with the Trial Medicine VEERIYA VIRUTHI 
CHOORANAM with milk, twice a day for 48 days. The disease and treatment are 
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based primarily on the derangement of Mukkutram, which again is based on the 
Pancha bootham theory. Incidence of Aan maladu and treatment are also based on 
these primary principles of Siddha medicine. The bootham raises azhal kuttram 
in the body and so as lead to general weakness and reduced sperm cell 
production. Increased azhal kuttram is brought to normal mainly by enippu suvai 
and thuvarpu suvai. These sweet and astringent tastes have the cool potency by 
nature. 
A. Earth + Water = Sweet 
 
B. Earth + Air = Astringent. 
            Thus they decrease the azhal kuttram. Sweet taste increases the 
spermatogenesis. So I conclude the trial drugs cures the Aan Maladu and it comes 
under the Ethirurai Maruthuvam. 
 
IMPROVEMENT:  
            Among the total 20 patients all were improved both subjectively and 
objectively. Clinical symptoms before and after treatment were noted. To obtain 
prognosis of each clinical symptom, the following formulae was used 
 
 
 
 
 
 
 
 
Semen Analysis: 
 
 
Before treatment 
 
 
20% of cases sperm count had  1-10 million/cumm, 45%  of cases sperm count 
had 11-20 million/cumm, 25% cases sperm count had 21-30 million/cumm, 10% of 
cases sperm count had 41-50 million/cumm  
After treatment 
 
5% of cases sperm count had  1-10 million/cumm, 20% cases sperm count 
had 21-30 million/cumm, 10% of cases sperm count had 31-40 million/cumm, 35% 
of cases sperm count had 41-50 million/cumm, 25% of cases sperm count had 51-60 
million/cumm, 5% of cases sperm count had 61-70 million/cumm,  
 
             No. Of cases after treatment      ×100 
           No. of cases before treatment 
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Bio Statistical study: 
The p value is highly significant (p<0.001).  So the treatment was significantly 
improving the Semen count (millions/cu mm) and semen motility.  
Since the p value is significant in all symptoms. So there is significant 
reducing of symptoms among the patients for the treatment of Aan Maladu(Male 
Infertility). Hence it is concluded that the treatment was effective and significant. 
 
OVER ALL RESULT: 
Out of 20 patients, 11 cases (55%) shows good result, 6 cases (30%) shows moderate 
result, 3 cases (15%) shows poor result. 
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                                               SUMMARY 
 
 
 
 
                       The aim of the study is to increase the sperm count and sperm 
motility in  male  infertility  patient.  The  trial  medicine  Veeriya viruthi Chooranam  
was prepared as per literature. The duration of the trial period is 48 days. The trial 
dose is Veeriya viruthi Chooranam  1 gm. twice a day with cow‟s milk.  
                I had selected 20 patients for the trial based on  Inclusion and 
Exclusion criteria. Before treatment routine blood, urine and semen analysis taken in 
all 20 patients. Siddha methods like udal thathukkal, Envagai thervu, Neerkuri and 
Neikuri were noted in case sheet proforma. Patients were instructed to come for next 
review once in 7 days.  
Age: 
             Most of the patients were in the age group between 31-40 years. 
Thinai: 
 
            Most of the patients were from Neithal Thinai 70%. 
 
Kaalam: 
 
            Seasonal Variances do not have any impact for affecting the people. 
 
Occupation: 
 
The disease is more common in people working in hot atmosphere like Drivers       
and Labourers. 
 
Diet & Personal habits: 
 
People with habit of taking Vegetarian and Mixed Diet, smoking, Alcoholic 
has more incidence of the disease. 
Mukkutrum: 
 
In Vali, Abaanan, Koorman, Viyanan and Devathathan, In Pitham Anal, 
Sadhagam, Aalosagam, and in Iyyam Tharpagam and Sandhigam were affected in 
most of the cases. 
Udal Thathugal: 
 
           Saaram, and sukkilam were affected in all the patients. 
 
Naadi: 
 
           Pithavaatham naadi was most common naadi felt. 
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Results after treatment: 
      
               Veeriya Viruthi Chooranam showed good results with relieving symptoms in 
almost 70% patients. 
 
 55% of patients show good improvement, 30% of patients shows moderate 
improvement and in 15% of patients poor improvement was observed. 
. 
 
The pharmacological studies reveal that Veeriya Viruthi Chooranam  had 
good spermatogenesis effect in rats. The toxicity study revealed that there were no 
signs of toxicity as could be judged by the absence of undesirable clinical 
manifestations and no alteration in bio chemical markers. 
            The bio-statistical report of the clinical trial shows significant result. 
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CONCLUSION 
 
 
 
 
 AAN MALADU (Male infertility) is primarily due to the derangement of pitham. 
  Veeriya viruthi Chooranam predominating with Inippu and Thuvarppu taste 
       respectively neutralizes the pitham. 
 From the pre-clinical pharmacological studies it is evident that the medicine 
was significant Spermatogenic activity. 
 The Veeriyaviruthi Chooranam does not produce any toxicity in preclinical 
study. So it is non-toxic and safe drug for Aan maladu. 
 From the preclinical study Veeriyaviruthi Chooranam increase the sperm motility. 
 No adverse effect was reported during the course of the treatment. 
 The trial medicine gave maximum relief from the symptoms of Aan maladu. 
 The preparation of trial drug is too easy and the cost effect is economically. 
 Therefore the author concluded that the trial medicine VEERIYA VIRUTHI    
      CHOORANAM should be a very good remedy for Aan maladu (Male Infertility). 
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ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Veeriya Viruthi Chooranam was carried 
out as per OECD guideline (Organization for Economic Co-operation and 
Development) Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423 (66). The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Veeriya Viruthi Chooranam.  
IAEC SU/CLATR/IAEC/IV/021/2016 
 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Veeriya Viruthi 
Chooranam 2000mg/kg (p.o). The animals were observed continuously for first 72 h 
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and then 14 days for emerging signs of behavioral changes, body weight changes and 
for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407 
(67)
. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
 
IAEC SU/CLATR/IAEC/IV/021/2016 
 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
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The animals were randomly divided into control group and drug treated groups 
for two different doses viz. low dose (200 mg/kg b.w) and high dose (400 mg/kg b.w). 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Veeriya Viruthi Chooranam 200 mg/kg b.w 
(p.o) and group III received high dose of Veeriya Viruthi Chooranam 400 mg/kg b.w 
(p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28th day, the animals were fasted for overnight 
with free access to water. On 29th day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes.  
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Biochemical analysis 
(68)
 
Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
Histopathological evaluation 
(69)
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes and 
ovary. Histological slides of organs were made and observed under the microscope.  
The pathological observations of cross section of these organs were performed on 
gross and microscopic bases. Histological examinations were performed on the 
preserved tissues with particular emphasis on those which showed gross pathological 
changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 
treatment group.  
Fecal Pellet Analysis 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean 
and sterile cage with blotting paper. The collected pellets were analyzed for 
consistency, color, Shape, Presence of blood cells etc 
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Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Point ended 
Colour Dark Green 
Mucous Shedding Mild 
Blood Cells Absent 
Signs of Infection None Observed 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft 
Shape Oblong Oblong Oblong 
Colour Brownish green Greenish Brown Greenish Brown 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection None Observed None Observed None Observed 
 
Muscle Grip Strength Analysis 
Methodology 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle force 
in vivo. Rats of control and drug treated group was allowed to hold the pull bar with both the 
hind limbs firmly then the animal was gently pulled back with the tail until the animal lost the 
grip toward the bar. The procedure was repeated to get the average value. Muscle grip ness of 
the drug treated group was compared to that of the control rat to ensure the change in 
coordination.  
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
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RESULTS 
Assessment of clinical signs in rats treated with Veeriya Viruthi Chooranam on 
Acute toxicity study 
Parameter Group I 
Clinical Signs Parameters for 
the duration of 14 days 
Test Drug 2000mg/ 
Kg    
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine pH 7 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
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Quantitative data on the body weight of rats treated with Veeriya Viruthi 
chooranam in Acute toxicity study 
Group I   Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
             184.2              187 
Std. Deviation 
             7.026              6.164 
Std. Error 
             2.868              2.517 
Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
 
Assessment of clinical signs in rats treated with Veeriya Viruthi Chooranam on 
Sub-Acute toxicity study 
Parameter         Group I      Group II     Group III 
Clinical Signs 
Parameters for the 
duration of 28 days Control 
Test Drug 200mg/ 
Kg    
Test Drug 400mg/ 
Kg    
Number of animals 
observed 
3 Male and 
 3 Female 
3 Male and 
 3 Female 
3 Male and 
3Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Absence 
Touch Response Normal Normal Normal 
Response to Sound Normal Response Normal Response Normal Response 
Response to Light Normal Response Normal Response Normal Response 
Mobility Normal Normal Normal 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety None Observed None Observed None Observed 
Muscular 
coordination Normal Normal Normal 
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Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis No Abnormality No Abnormality No Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 6 6 6 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
 
Effect of Veeriya Viruthi Chooranam on Body weight of Rats in Sub-acute 
toxicity study 
Group I      Before Treatment Weight in Gms     After Treatment Weight in Gms 
Mean 
                        189.5 193.8 
Std. Deviation 
5.788 5.492 
Std. Error 
2.363 2.242 
Group II     Before Treatment Weight in Gms     After Treatment Weight in Gms 
Mean 
183 195.2 
Std. Deviation 
5.831 4.875 
Std. Error 
2.38 1.99 
Group III     Before Treatment Weight in Gms     After Treatment Weight in Gms 
Mean 
176 183 
Std. Deviation 
6.356 7.563 
Std. Error 
2.595 3.088 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Quantitative data on the food and water intake of rats treated with Veeriya 
Viruthi Chooranam for 28 days in Sub-acute toxicity study 
               GROUP I Food intake Water intake 
Mean       17.33        33.92 
Std. Deviation        3.82        2.727 
Std. Error        1.91        1.363 
                 GROUP II Food intake Water intake 
Mean        16.58        31.33 
Std. Deviation        4.324        1.054 
Std. Error        2.162        0.527 
                  GROUP III   Food intake Water intake 
Mean        17.08         31.33 
Std. Deviation        2.132         1.305 
Std. Error        1.066         0.6526 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Veeriya Viruthi Chooranam on Haematology profile of rats in sub-acute 
toxicity study  
GROUP I 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 12.1 6.867 649.7 64.62 18.48 32.88 12.15 
Std. 
Deviation 1.334 1.084 144.9 2.501 2.137 1.61 1.42 
Std. Error 0.5447 0.4425 59.14 1.021 0.8723 0.6575 0.5795 
GROUP II 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 12.07 6.233 612.5 63.68 17.97 32.39 11.5 
Std. 
Deviation 0.9812 0.8618 137.6 3.539 2.037 1.903 1.064 
Std. Error 0.4006 0.3518 56.16 1.445 0.8317 0.777 0.4344 
GROUP 
III 
 WBC 
count 
(×10
3
 µl) 
RBC (×10 
6
 µl) 
PLT (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 12.78 6.633 854.8 61.6 20.05 32.32 12.98 
Std. 
Deviation 2.004 1.316 134.7 4.856 1.468 1.609 1.238 
Std. Error 0.8183 0.5371 54.97 1.983 0.5993 0.657 0.5056 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Effect of Veeriya Viruthi Chooranam on Haematology profile of rats in sub-acute 
toxicity study. 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 77.38 3.15 2.517 1.583 0.3333 5.567 
Std. 
Deviation 7.903 0.8264 0.9196 0.2787 0.5164 1.181 
Std. Error 3.226 0.3374 0.3754 0.1138 0.2108 0.4821 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 79.77 2.5 2.133 1.583 0.5 4.817 
Std. 
Deviation 8.493 0.506 0.6861 0.2041 0.5477 1.761 
Std. Error 3.467 0.2066 0.2801 0.08333 0.2236 0.719 
GROUP 
III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 71.48 5.1 1.967 1.35 0.1667 5.167 
Std. 
Deviation 5.504 0.6723 0.5125 0.3146 0.4082 1.414 
Std. Error 2.247 0.2745 0.2092 0.1285 0.1667 0.5772 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Veeriya Viruthi Chooranam on Serum Bio-chemistry profile of rats in 
sub-acute toxicity study 
GROUP 
I 
Blood 
sugar 
® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 79.83 18.17 0.8333 125.8 88.17 61.67 45 17.57 
Std. 
Deviation 12.17 2.927 0.1862 9.827 13.17 10.89 5.02 3.546 
Std. Error 4.969 1.195 0.07601 4.012 5.375 4.447 2.049 1.447 
GROUP 
II 
Blood 
sugar 
® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 79.67 10.67 0.8333 104.2 79.17 52 40 19.97 
Std. 
Deviation 7.891 2.658 0.2875 22.34 12.95 12.51 17.67 1.306 
Std. Error 3.221 1.085 0.1174 9.119 5.288 5.106 7.216 0.5333 
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Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Veeriya Viruthi Chooranam on Serum Bio-chemistry profile of rats in 
sub-acute toxicity study 
GROUP I 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) 
(AST)  (IU/ml) (ALT) (IU/L) (ALP)(IU/L) 
Mean 3.833 4.183 104 33.67 186 
Std. Deviation 0.432 0.5879 21.16 10.48 41.02 
Std. Error 0.1764 0.24 8.637 4.279 16.75 
GROUP II 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) 
(AST)  (IU/ml) (ALT) (IU/L) (ALP)(IU/L) 
Mean 6.017 3.9 81.67 32.17 170.2 
Std. Deviation 0.7985 0.8462 6.947 9.453 50.65 
Std. Error 0.326 0.3454 2.836 3.859 20.68 
GROUP III 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) 
(AST)  (IU/ml) (ALT) (IU/L) (ALP)(IU/L) 
Mean 3.833 2.85 104.3 18.67 194.2 
Std. Deviation 0.7118 0.9607 27.66 3.67 35.95 
Std. Error 0.2906 0.3922 11.29 1.498 14.68 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
 
 
GROUP 
III 
Blood 
sugar 
® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 76.17 15.33 0.8167 97.67 82.33 58 45.67 13.97 
Std. 
Deviation 11.37 3.266 0.2137 8.311 9.438 9.099 7.285 1.763 
Std. Error 4.643 1.333 0.08724 3.393 3.853 3.715 2.974 0.7196 
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Quantitative data on absolute organ weight of rats treated with Veeriya Viruthi 
Chooranam for 28 days in Sub-acute toxicity study 
GROUP 
I 
HEART 
(gms) 
 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.6833 6.335 1.607 0.5167 1.567 1.683 1.25 3.067 1.167 
Std. 
Deviation 0.1065 1.142 0.2337 0.1941 0.216 0.1722 0.345 1.172 0.05774 
Std. Error 0.04349 0.4663 0.09542 0.07923 0.08819 0.07032 0.1408 0.6766 0.03333 
GROUP 
II 
HEART 
(gms) 
 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.7067 5.428 1.438 0.5667 1.45 1.6 1.383 2.867 1.367 
Std. 
Deviation 0.128 1.119 0.27 0.2066 0.2258 0.2098 0.3869 0.4726 0.05774 
Std. Error 0.05226 0.4568 0.1102 0.08433 0.0922 0.08563 0.1579 0.2728 0.03333 
GROUP 
III 
HEART 
(gms) 
 
LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.6733 6.702 1.405 0.7 1.633 1.633 1.283 3.067 1.2 
Std. 
Deviation 0.1082 0.8958 0.1963 0.1897 0.1506 0.2338 0.4355 0.8505 0.1 
Std. Error 0.04417 0.3657 0.08016 0.07746 0.06146 0.09545 0.1778 0.491 0.05774 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett’s test. 
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HISTOPATHOLOGY REPORT 
BRAIN  
               Histology of brain revealed the presence of normal cortex showing neurons, 
glial cells and capillaries. Section of cerebellum shows distinct molecular and granular 
layer. Neuronal architecture appears normal with sufficient numbers. Arrangement of 
the neurons appears intact with no sings of degeneration or apoptotic changes were 
observed in sample belongs to group I,II and III. 
LUNG  
               Light microscopic examination of lung revealed normal alveoli and alveolar 
sac with no signs of infiltration in both control and treated rats. 
HEART  
             Atrial and ventricular wall of both the heart sample appears normal. 
Sarcoplasmic region of myocardium appears normal. Appearance of cardiomyocyte 
was normal with dark nuclear region in samples belongs to group I, II and III. 
STOMACH  
               Light microscopic observation stomach reveals normal histology of gastric 
wall composed of normal mucosa, muscularismucosa, submucosa, muscularispropiria 
and adventitia. No signs of ulceration were observed in sample belongs to group I, II 
and III. 
SPLEEN  
             Appearance of central artery and marginal sinus are normal . Lymphoid 
follicles appears normal . Marginal sinus (MS) of the rat and its sinus lining cells 
appears normal. Erythropoietic cells (EP) are scattered throughout the red pulp of both 
control and treated rats. 
LIVER   
               Hepatocellular architecture, including hepatic sinusoid and hepatic cord was 
normal Central vein appears prominent with no signs of cellular infiltration were 
observed in sample belongs to group I, II and III. 
KIDNEY  
              Lumen of vessels and bowman’s space appears normal. Appearance of 
Podocytes and parietal epithelium in the glomeruli appears normal in sample belongs 
to group I,II and III. 
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TESTES  
             Presence of mature somatic cells project the perfect histomorphology of 
testicular cells in this group. Primary spermatocytes with large centered nucleus and 
dense chromatin were observed in sample belongs to group I,II and III. 
UTERUS 
             Appearance of endometrium, myometrium and uterine glands was normal. 
Arrangement of stratum basale, functionale and surface epithelium seems normal in 
samples belongs to group I,II and III. 
OVARY  
            Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
Appearance of antral follicle, primary oocyte and secondary follicles are normal in 
sample belong to group I,II and III. 
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Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
           Low Power Magnification 10X 
           
                     GROUP I             GROUP II               GROUP III  
           High Power Magnification 40X 
         
              GROUP I            GROUP II    GROUP III  
 
Histopathology of Heart (Male Rat) in Sub-acute toxicity Study 
          Low Power Magnification 10X 
     
            GROUP I           GROUP II    GROUP III 
            High Power Magnification 40X 
          
         GROUP I                       GROUP II    GROUP III 
                                                                                      HISTOPATHOLOGY MALE 
 
Veeriya viruthi Chooranam for Aan Maladu  Page 121 
 
Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
               Low Power Magnification 10X 
          
                       GROUP I              GROUP II    GROUP III 
             High Power Magnification 40X 
           
                       GROUP I           GROUP II     GROUP III 
 
Histopathology of Liver (Male Rat) in Sub-acute toxicity Study 
           Low Power Magnification 10X 
            
           GROUP I            GROUP II   GROUP III 
        High Power Magnification 40X 
           
          GROUP I              GROUP II    GROUP III 
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Histopathology of Lung (Male Rat) in Sub-acute toxicity Study 
         Low Power Magnification 10X 
     
            GROUP I          GROUP II    GROUP III 
             High Power Magnification 40X 
             
                 GROUP I               GROUP II    GROUP III 
 
Histopathology of Spleen (Male Rat) in Sub-acute toxicity Study 
        Low Power Magnification 10X 
       
            GROUP I                GROUP II    GROUP III 
             High Power Magnification 40X 
          
                GROUP I            GROUP II    GROUP III 
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Histopathology of Stomach (Male Rat) in Sub-acute toxicity Study 
               Low Power Magnification 10X 
        
            GROUP I            GROUP II   GROUP III 
             High Power Magnification 40X 
        
         GROUP I                      GROUP II    GROUP III 
 
Histopathology of Testes (Male Rat) in Sub-acute toxicity Study 
             Low Power Magnification 10X 
       
          GROUP I          GROUP II    GROUP III 
                 High Power Magnification 40X 
        
          GROUP I          GROUP II    GROUP III 
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Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
        
           GROUP I             GROUP II             GROUP III 
High Power Magnification 40X  
          
          GROUP I              GROUP II      GROUP III  
 
Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
             GROUP I          GROUP II    GROUP III  
High Power Magnification 40X 
      
             GROUP I          GROUP II    GROUP III 
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Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
              GROUP I              GROUP II               GROUP III 
High Power Magnification 40X 
      
              GROUP I             GROUP II    GROUP III 
 
Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
            GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
      
            GROUP I          GROUP II    GROUP III 
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Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
              GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
      
              GROUP I          GROUP II    GROUP III 
 
Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
            GROUP I          GROUP II      GROUP III 
High Power Magnification 40X 
       
               GROUP I          GROUP II    GROUP III 
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Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
              GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
     
                  GROUP I          GROUP II    GROUP III 
 
Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
              GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
     
                GROUP I          GROUP II    GROUP III 
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Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
 
Low Power Magnification 10X 
     
                 GROUP I          GROUP II    GROUP III 
 
High Power Magnification 40X 
     
            GROUP I          GROUP II    GROUP III 
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Pharmacological Evaluation of Veeriya Viruthi Chooranam on Gentamicin-
Induced testicular toxicity in wistar rats 
 
IAEC : SU/CLATR/IEAC/VII/048/2016 
Animals 
Healthy adult Wistar albino male rats weighing between 230-250 g were used 
for the study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit . A 12 light / dark cycle were 
maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study.The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/048/2016 
Experimental Methodology 
The animals were grouped into four groups of 6 animals each. Group I 
(Control group) -received normal saline, Group II – Disease control group rats 
received Gentamycin 50mg/kg, i.p from day 1 to 30. Group III (low dose treatment 
group) animal received 200 mg/kg of Veeriya Viruthi Chooranam 1 hr prior to 
gentamycin injection from day 1 to 30. Group III (High dose treatment group) animal 
received 400 mg/kg of Veeriya Viruthi Chooranam 1 hr prior to gentamycin injection 
from day 1 to 30. 
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Sample Collection 
Determination of sperm count and motility 
24 hrs after last dose of drug administration the animals was sacrificed for the 
assessment of sperm count. The testis was be decapsulated by isolating cauda epididymis the 
sperm will be released by cutting into phosphate buffer saline and 0.5% bovine serum 
albumin of pH 7. The homogenate was under room temp for 5 min and an aliquot was taken 
in leukocyte hemocytometer and discharged in neuabaurs counting chamber and count will be 
done in 4 chambers. Remaining part of 0.3 ml of plain slide and the sperm motility was 
analyzed with microscope.For morphological analysis PBS sperm suspension was admixed 
with 4 drops of eosin and thin smear of the same was made on to the glass slide and allowed 
to dry for further morphological analysis. 
Determination of Sperm Morphology 
Homogenate of about 0.5 ml was stained with eosin at room temperature for 30 mins 
and the slide was observed under microscope for sperm morphology. 
Histopathology of testes 
Testes was dissected out and fixed in 10% buffered neutral formal saline and 
processed. After fixation, a tissue was embedded in paraffin. Fixed tissues were cut at 10 µm 
and stained with hematoxylin and eosin. The sections were examined under light microscope 
and photomicrographs will be taken. 
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Effect of Veeriya Viruthi Chooranam on Sperm Count, Motility and Viability 
parameters on Gentamicin-Induced rats 
Group I 
Sperm Count             
X 10 6 
Sperm Motility 
(%) Viability (%) 
Mean 57.67 87.5 73 
Std. Deviation 3.933 8.503 2.53 
Std. Error 1.606 3.471 1.033 
Group II 
Sperm Count             
X 10 6 
Sperm Motility 
(%) Viability (%) 
Mean 16.67 17.67 14.17 
Std. Deviation 4.082 5.854 3.189 
Std. Error 1.667 2.39 1.302 
Group III 
Sperm Count             
X 10 6 
Sperm Motility 
(%) Viability (%) 
Mean 29.5 41 35.33 
Std. Deviation 3.619 8.099 5.203 
Std. Error 1.478 3.307 2.124 
Group IV 
Sperm Count             
X 10 6 
Sperm Motility 
(%) Viability (%) 
Mean 45 54 45.5 
Std. Deviation 4.195 7.071 5.32 
Std. Error 1.713 2.887 2.172 
Values are mean ± S.D / S.E (n = 6 per group) 
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Microscopic View of Neubauer’s Chamber on Sperm Count 
                            Control Group                                   Gentamycin Induced group                    
         
 
 
         
           Gentamycin+ 200 mg/kg of VVC              Gentamycin+ 400 mg/kg of VVC 
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Microscopic View of Sperm morphology Stained with Eosin dye 
(Low Magnification) 
                    Control Group                                   Gentamycin Induced group 
                       
 
                      
 
               Gentamycin+ 200 mg/kg of VVC              Gentamycin+ 400 mg/kg of VVC 
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Microscopic View of Sperm morphology Stained with Eosin dye 
(High Magnification) 
                Control Group                                  Gentamycin Induced group 
        
 
        
               Gentamycin+ 200 mg/kg of VVC                Gentamycin+ 400 mg/kg of VVC 
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Microscopic View of Sperm Motility of Control and drug treated rats  
                   Control Group                                Gentamycin Induced group 
         
 
         
              Gentamycin+ 200 mg/kg of VVC                  Gentamycin+ 400 mg/kg of VVC 
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Histopathology of Rat Testes (H&E) Staining 
Low Power Magnification 10 X 
                      Control Group                                   Gentamycin Induced group  
         
 
         
                 Gentamycin+ 200 mg/kg of VVC              Gentamycin+ 400 mg/kg of VVC 
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Histopathology of Rat Testes (H&E) Staining 
High Power Magnification 40 X 
                        Control Group                                     Gentamycin Induced group 
       
 
       
              Gentamycin+ 200 mg/kg of VVC               Gentamycin+ 400 mg/kg of VVC 
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Pathology Report 
 Light microscopic observation of group I rats revealed well differentiated germ cells with 
respect of spermatogonia includes spermatid and sperm. Normal sertoli cell properly 
aligned on the basement membrane with oval dome shaped nucleus shows the normal 
morphology of the seminiferous tubule. 
 Marginal interstitial fibrosis was observed in testicular tissue sample of rats belongs to 
group II. Significantly reduced number of primary spermatocytes was observed. 
Hypertrophic swollen seminiferous tubule with spacious lumen of sertoli cells was 
observed in sample belongs to group II. 
 Seminiferous tubule and interstitial leydig cells appears atrophic with occasional evidence 
of collagen deposition.  Increased number of early spermatids as an evidence of sperm 
rejuvenation was observed in the sample belongs to group III. 
 Significantly increased level of pooled sperm oriented towards the center of sertoli cells 
with cluster of tail projected outside was observed in sample belongs to group IV. 
Primary spermatocytes with large centered nucleus and dense chromatin were observed in 
this group. 
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1. Determination of Loss on Drying 
                       Place about 10 g of drug (without preliminary drying) after accurately 
weighing (accurately weighed to within 0.01 g) it in a tared evaporating dish. After 
placing the above said amount of the drug in the tared evaporating dish dry at 105º for 
5 hours, and weigh. Continue the drying and weighing at one hour interval until 
difference between two successive weighings corresponds to not more than 0.25 per 
cent. Constant weight is reached when two consecutive weighings after drying for 30 
minutes and cooling for 30 minutes in a desiccator, show not more than 0.01 g 
difference. 
2. Determination of Total Ash  
                Incinerate 2 g accurately weighed, of the drug in a tared silica dish at 450ºC  
until free from carbon, cool and weigh. If a carbon free ash cannot be obtained in this 
way, exhaust the charred mass with hot water, collect the residue on an ashless filter 
paper, incinerate the residue and filter paper, add the filtrate, evaporate to dryness, and 
ignite at a temperature not exceeding 450ºC. Calculate the percentage of ash with 
reference to the air-dried drug. 
3. Determination of Water Soluble Ash  
                Boil the ash obtained in the above test for 5 minutes with 25 ml of distilled 
water repeatedly; collect the insoluble matter on an ashless filter paper, and ignite to 
constant weight. Calculate the percentage of water soluble ash with reference to the 
air dried drug. 
4. Determination of Acid Insoluble Ash  
                Boil the ash obtained in the above test for 5 minutes with 25 ml of dilute 
hydrochloric acid repeatedly; collect the insoluble matter on an ashless filter paper, 
wash with hot water and ignite to constant weight. Calculate the percentage of acid-
insoluble ash with reference to the air dried drug. 
5. Determination of Alcohol Soluble Extractive 
               Macerate 5 g of the air dried drug, coarsely powdered, with 100 ml of 
Alcohol of the specified strength in a closed flask for twenty-four hours, shaking 
frequently during six hours and allowing to stand for eighteen hours. Filter rapidly, 
taking precautions against loss of solvent, evaporate 25 ml of the filtrate to dryness in 
a tared flat bottomed shallow dish, and dry at 105º, to constant weight and weigh. 
Calculate the percentage of alcohol-soluble extractive with reference to the air-dried 
drug. 
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6. Determination of Water Soluble Extractive 
                  Proceed as directed for the determination of Alcohol-soluble extractive, 
using distilled water instead of ethanol. 
 
7. Determination of pH 
                  Take 10g of sample, add 100 ml of distilled water, stir well and filter.  Use 
the filtrate for the experiment. Switch on the instrument. Give 30 minutes time for 
warming pH meter.  Introduce the pH 4 solution first and adjust the pH meter by using 
the knob to 4.00 for room temperature 20°C, 4.01 for room temperature 25°C, 4.02 for 
room temperature 30°C.  Introduce the pH 7 solution and adjust the pH meter to 7 by 
using the knob.  Introduce the pH 9.2 solution and check the pH reading without 
adjusting the knob.  Then introduce the sample solution and note the reading. Repeat 
the test four times and take the average reading as result. 
 
Sample Name: Veeriya Viruthi Chooranam  
Stationary Phase - Silica Gel 60 F254 
Mobile Phase - Toulene : Ethyl Acetate : Formic Acid (5:1;0.2 v/v/v) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  = 366 nm  
 
  = 575 nm (Derivatized) 
 
Color Rf  value(s) Color Rf value(s)  
Maroon 0.59 Ash  0.04  
Light Green 0.62 Ash 0.15  
Pink 0.67 Ash  0.21  
Sky Blue 0.71 Light Blue 0.53  
Sky Blue 0.75 Light Blue 0.61  
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HPTLC Chromatogram @ 366 nm:  
 
Peak Table @ 366 nm:  
 
3D Chromatogram @ 366 nm: 
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           BIO-CHEMICAL ANALYSIS 
 
BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINES 
 
Preparation of Sodium Carbonate extract: 
                  2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken 
in a 100 ml beaker and 20 ml of distilled water is added. The solution is boiled 
for 10 minutes, cooled and then filtered. The filtrate is called sodium carbonate 
extract. 
S.No EXPERIMENT OBSERVATION INFERENCE 
I TEST FOR ACID RADICALS 
1a Test for Sulphate 
 
2 ml of the above prepared 
extract is taken in a test tube. To 
this add 2ml of 4% Ammonium 
oxalate solution. 
Absence of 
 
White Precipitate 
Absent 
b 2ml of extract is added with 2ml 
 
of dilute hydrochloric acid until 
the effervescence ceases off. 
Then 2ml barium chloride 
solution is added. 
Absence of 
 
White Precipitate 
Absent 
2 Test for Chloride: 
 
2ml of extract is added with 
dilute nitric acid till the 
effervescence ceases. Then 2ml 
of silver nitrate solution is 
added. 
Absence of white 
 
precipitate 
 
Obtained 
Absent 
3 Test for Phosphate 
 
2ml of the extract is treated 
with 2 ml of Ammonium 
molybdate solution and 2ml of 
concentrated nitric acid. 
Yellow precipitate 
 
Obtained 
Present 
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4 Test for Carbonate: 
 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution. 
Absence of white 
 
Precipitate 
Absent 
5 Test for Sulphide: 
 
1 gm of the substance is treated 
with 2ml of concentrated 
Hydrochloric acid 
Rotten egg smelling Present 
6 Test for Nitrate: 
 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid 
and viewed the test tube 
vertically down. 
Absence of reddish 
 
brown gas. 
Absent 
7a Test for Fluoride and oxalate 
 
2ml of the extract is added with 
 
2ml of dilute acetic acid and 
 
2ml of calcium chloride 
solution and heated. 
White precipitate Absent 
b 5 drops of clear solution is 
 
added with 2ml of dilute 
sulphuric acid and slightly 
warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added. 
KMNO4 solution 
 
Discolourisation 
obtained 
Absent 
8 Test for Nitrite 
 
3 drops of the extract is placed 
on a filter paper. On that, 2 
drops a Acetic Acid and 2 
drops of Benzidine solution is 
placed. 
Absence of 
 
yellowish red colour 
Absent 
9 Test for Borate 
 
2 pinches of the substance is 
Absence of Green 
 
tinged flame 
Absent 
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 made into paste by using 
 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
  
II TEST FOR BASIC RADICALS 
10 Test for lead 
 
2 ml of the extract is added 
with 2 ml of Potassium iodide 
solution. 
Absence of Yellow 
 
precipitate 
Absent 
11a Test for Copper 
 
One pinch of substance is made 
into paste with concentrated 
Hydrochloric acid in a watch 
glass and introduced into the 
non luminous part of the flame. 
Absence of Bluish 
 
green coloured 
flame. 
Absent 
b 2ml of the extract is added with 
 
excess of Ammonia solution 
Absence of deep 
 
blue 
Absent 
12 Test for Aluminium 
 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in 
drops to excess 
Absence of White 
 
Precipitate. 
Absent 
13a Test for Iron 
 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
Solution is added. 
Blood red colour Present 
b To the 2 ml of extract, 2 ml of 
 
Ammonium Thiocyanate 
solution and 2 ml of 
concentrated Nitric Acid is 
added. 
Blood red colour 
 
obtained 
Present 
14 Test for Zinc 
 
To the 2 ml of extract Sodium 
Absence of White 
 
precipitate. 
Absent 
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  Hydroxide solution is added in  
drops to excess. 
  
15 Test for Calcium 
 
2 ml of the extract is added 
with 2 ml of 4% Ammonium 
Oxalate solution. 
Absence of White 
 
precipitate. 
Present 
16 Test for Magnesium 
 
2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
 
precipitate. 
Absent 
17 Test for Ammonium 
 
2 ml of extract few ml of 
Nessler‟s Reagent and excess 
of Sodium Hydroxide solution 
are added. 
Absence of 
 
Reddish brown 
precipitate 
Absent 
18 Test for Potassium 
 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Absence of Yellow 
 
precipitate 
Absent 
19 Test for Sodium 
 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame 
Absence of Yellow 
 
colour flame 
Absent 
20 Test for Mercury 
 
2 ml of the extract is treated 
with 2 ml of Sodium 
Hydroxide solution. 
Absence of yellow 
 
Precipitate 
Absent 
21 Test for Arsenic 
 
2 ml of extract is treated with 2 
Absence of 
 
Yellow precipitate 
Absent 
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 ml of silver Nitrate solution   
22 Test for Starch 
 
2ml of extract is treated with 
weak iodine solution 
Absence of 
 
Blue colour 
Absent 
23 Test of reducing Sugar 
 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 10 drops of 
the extract and again boiled for 
2 minutes. The colour changes 
are noted. 
Green colour Present 
24 Test of the alkaliods 
 
2ml of the extract is treated 
with 2ml of potassium lodide 
solution. 
Absence of 
 
Red colour 
Absent 
25 Test of the proteins 
 
2ml of the extract is treated 
with 2ml of 5% NaOH ,mix 
well and add 2 drops of copper 
sulphate solution. 
Absence of 
 
Violet colour 
Absent 
 
 
 
RESULTS: 
 
 
The given sample (VEERIYA VIRUTHI CHOORANAM) contains 
 
Phosphate, Sulphide, , Iron,Calcium, Reducing sugar. 
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BIO STATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Aan Maladu: 
            The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
 
S. No Symptoms Before Treatment After Treatment 
n% n% 
1. Premature Ejaculation 12(60) 4(20)** 
2. Erectile Dysfunction 8(40) 2(10)** 
3. Nocturnal Emission 9(45) 3(15)** 
           McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 20 
Inference:  
Since the p value is significant in all symptoms. So there is significant reducing of 
symptoms among the patients for the treatment of Aan Maladu(Male Infertility). 
Hence it is concluded that the treatment was effective and significant. 
BIOSTATISTICAL ANALYSIS 
Effect of Medicine… on Semen Count in human subjects 
S.No Semen Count(million/cumm) 
Before Treatment After Treatment 
1 22 
 
50 
 
2 13 
 
30 
 
3 25 
 
58 
 
4 12 
 
55 
 
5 22 
 
24 
 
6 19 
 
60 
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7 42 
 
60 
 
8 15 
 
48 
 
9 21 
 
40 
 
10 45 48 
 
11 18 
 
50 
 
12 9 
 
52 
 
13 16 
 
48 
 
14 15 
 
45 
 
15 8 
 
50 
 
16 14 
 
67 
 
17 10 
 
25 
 
18 23 
 
38 
 
19 3 
 
5 
 
20 15 
 
30 
 
 
Software: spss17 version 
Variables: Semen Count (millions/cu mm) – before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.436 
Before and after treatment mean difference: 25.35±14..04 
P Value (2 tailed): p<0.001. 
Inference:  
The p value is highly significant (p<0.001).  So the treatment was significantly improving the 
Semen count (millions/cu mm). 
 
 
 
 
                                                                                   BIOSTATISTICAL ANALYSIS 
 
Veeriya viruthi Chooranam for Aan Maladu Page 154 
 
BIOSTATISTICAL ANALYSIS 
Effect of Medicine… on Semen Motility(%) in human subjects 
S.No Semen Motility (AM%) 
Before Treatment After Treatment 
1 18  58 
2 8 32 
3 18  56  
4 24  60 
5 10  22  
6 20 55 
7 10  35 
8 18 65 
9 8 40 
10 15   25  
11 10  55 
12 15 55 
13 12  53  
14 15  58 
15 22  62  
16 15 60 
17 13  55 
18 15 45 
19 7 15 
20 17   40  
 
Software: spss17 version 
Variables: Semen Motility (%) – before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.578 
Before and after treatment mean difference: 33.30±2.80 
P Value (2 tailed): p<0.001. 
Inference:  
The p value is highly significant (p<0.001).  So the treatment was significantly improving the 
Semen Motility (%). 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
A CLINICAL STUDY ON “VEERIYA VIRUTHI CHOORANAM” IN THE 
TREATMENT OF 
“AAN MALADU” (MALE INFERTILITY) 
 
           INFORMED CONSENT FORM 
 
           “I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my 
satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
            "I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
Signature of the Guide:    Signature of the Investigator:   
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tPuPatpUj;jp R+uzk;
 
tPuPatpUj;jp R+uz
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ANNEXURE  
CASE SHEET PROFORMA FOR “AAN MALADU” 
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2015 - 2017 
 
Op No/ Ip No            :   Occupation  :    
Ward No                   :   Income : 
Bed No                     :    Nationality : 
Name                         :     Religion : 
Age                           :     D.O.A  : 
Sex                           :      D.O.D  : 
Address                     :      Diagnosis : 
 
1. Complaints and duration: 
 
 
2. History of present illness : 
 
3. History of past illness                   : 
Mumps / Orchitis                               : 
Yes No 
Prostatitis                                           :  
STD                                                    : 
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6. Sexual history 
 
Diabetes mellitus                                : 
Hypertension                                      : 
Cardiac diseases                                 : 
4. Surgical history                            : 
  
Hydrocele                                          :   
Varicocele                                          :   
Blockage of vas                                  :   
Hernia                                                 :   
Obstruction of ejaculatory duct          :   
Trauma                                               :   
5. Personal history  
Habitis           
  
A.Diet                  : 
 B.Marital status               :     
 C.Durationofmarriage(yr):       
 D.Consanguineous               :      
 
Veg 
Single 
Yes 
 
Non veg 
Married 
No 
A
. 
Erectile function                     : Normal Affet
ed B
. 
Ejaculatory effect                   : Normal Affec
ted C
. 
Frequency of intercourse        : (per/month)  
D
. 
Frequency of masturbation    : (per/month)  
E
. 
Lubricant                                : Yes No 
F
. 
Nocturnal Emission                : Yes No 
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7.   Respiratory rate                         : 
 
8.   Blood pressure                            : 
 
9.   Pallor                                           : 
 
10. Cyanosis                                      : 
 
11. Jaundice                                      : 
 
12. Clubbing                                     : 
 
13. Lymphadenopathy                     : 
 
14. Acanthosis nigricans                  : 
15. Hisutiom                                      :  
EXAMINATION OF VITAL ORGANS 
1.   CVS                                        :           Normal                      Abnormal 
If abnormal details………………………………….. 
2.   CNS                                        :          Normal                      Abnormal 
If abnormal details………………………………….. 
3.   Respiratory system               :          Normal                      Abnormal 
If abnormal details………………………………….. 
4.   Digestive system                   :          Normal                      Abnormal 
If abnormal details………………………………….. 
5.   Urogenital system                 :          Normal                      Abnormal 
If abnormal details………………………………….. 
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LOCAL EXAMINATION 
INSPECTION: Yes No  
Hydrocele     : Yes      No  
Varicocele               : Yes               No 
 Inguinal Hernia              : Yes      No  
Filarial Scrotum     : Yes      No  
Both testicles present in scrotum   : Yes      No 
Painful coitus      : Yes      No 
Burning Micturition    : Yes              No  
Spermaturia    : Yes              No  
Emotional stress    : Yes              No  
Addiction                                                          :           Yes                                    No   
If yes specify:   
Bowel habit                                                 :          Regular 
Constipation 
Sleep                                                           :          Good               Disturbed 
Insomnia 
Presence of anxiety                             
FAMILY HISTORY: 
Yes No 
    No. of abortions his wife had 
: 
Yes No 
    Cardiovascular disease           
: 
Yes No 
    Tuberculosis                           
: 
Yes No 
 Others                                      
 If yes specify                          : 
Yes No 
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HISTORY OF CONGENITAL ANOMALIES 
 
Cryptorchidism                                 : 
Hypospadias                                      : 
Yes 
Yes 
No 
No 
 
 
   DRUG HISTORY 
Steroids                                              
: 
 
 
Yes 
 
Yes 
 
 
 No 
 
No 
Anti depressant                                    Yes No 
GENERAL EXAMINATION 
 
Physical build                                     
: 
 
 
 
 
 
Lean 
 
 
 
 
 
Normal 
 
 
 
 
 
O
b
es
e 
Body weight                                       
: 
   
Temperature                                       
: 
   
Pulse rate                                            
: 
   
Heart rate                                                
PALPATION 
Size and Consistency of  testicles       
 
 
 
 
Normal 
 
 
 
 
Abno 
 
 
 
 
r
m
al 
SIDDHA ASPECT NILAM 
Kurinchi(Hills Areas)                         :  
Mullai(Forest Areas)                          :  
Marutham(Fertile Areas)                   :  
Neithal(Sea Areas)                             :  
Palai(Desert Areas)                            :  
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PARUVA KALAM  
Kaar (Aavani-Puratasi) Aug-Sep       :        
 Koothir (Iypasi-Karthigai)Oct-Nov   :  
Munpani (Maargazhi-Thai)Dec-Jan   :       
  Pinpani (Maasi-Panguni)Feb-Apr      :  
Elavenil (Chithirai-Vaikasi)Apr-May :         
 Mudhuvenil (Aani-Adai)Jun-Jul        :  
YAAKKAI (UDAL NILAI) 
Vaatham                                     :  
Pittham                                       :  
Kabam                                        :      
 Kalappu                                      :  
GUNAM 
Satthuvam                                          :  
Rajotham                                            :  
Thamasam                                          :  
PORI/PULANGAL (SENSORY ORGANS) 
 Mei –Sensation                               Vaai – Taste                                    Kan – Vision                                         
Mooku - Smell                               Sevi – Hearing                                     
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KANMENTHRIYAM/KANNMAVIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam                               Kaal-Kamanam                                 Vaai-Vasanam                                    
Eruvaai- Visarkkam                 Karuvaai-Aanantham             
UTHKAAYA ATHAKAAYAM  
Puyam[forearm]                                  Sayam[arm]                                     Kaal[leg]                                            
Paaatham[feet]                                    
UYIR THATHUKKAL 
A.VATHAM 
Piranan ………….                                  Abanan …………….                                  
Viyanan  ………….                               Udanan ……………..                              
Samanan…………..                               Nagan……………….                                      
 Koorman ………….                              Kirukaran…………….                
 Devathathan…………                           Thananjeyan …………  
                     
B.PITHAM 
Anar pitham                                       : 
 Ranjaga pitham                                  :  
Saathaga pitham                                 :  
Pirrasaga pitham                                 :  
Alosaga pitham                                   
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C.KAPAM 
Avalambagam                                    :  
Kilethagam                                        : 
 Pothagam                                         :  
Tharpagam                                         :  
Santhigam                                         : 
UDALTHAATHUKKAL 
Saaram                                                :  
Senner                                                :  
Oon                                                     :  
Kozhuppu                                           :  
Enbu                                                   : 
 Moolai                                                :  
Sukkilam                                            : 
ENVAGAI THERVUGAL 
1.Naa                                                  : 
2.Niram                                              : 
3.Mozhi                                              : 
4.Vizhi                                                : 
5.Sparisam                                          : 
6.Malam                                             : 
7.Moothiram                                       :  
8.Naadi 
a)Neer Kuri                                        :  
b)Nei Kuri                        :        : 
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MALAM 
Niram                                   :  
Edai                                      :  
Erugal                                  :  
Elagal                                  : 
MOOTHIRAM 
1. Neerkuri             
Niram                         :  
Manam                       :  
Edai                            :  
Nurai                          :  
Enjal                           : 
2. Neikuri 
 
SIGNS AND SYMPTOMS: 
S
.
N
o 
Clinical Features Before Treatment During Treatment of every 7days 
        
1
. 
Premature ejaculation          
2
. 
Erectile dysfunction          
3
. 
Painful coitus          
4
. 
Nocturnal emission          
5
. 
Burning micturition          
 
LABORATORY  INVESTIGATION 
1. BLOOD                        :          AT                                                      BT 
TC 
DC 
ESR 
Bleeding time 
Clottingtime 
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Blood sugar 
Blood urea 
Serum cholesterol 
VDRL 
2. URINE  
Albumin Sugar Deposits 
3.SEMEN ANALYSIS 
Semen analysis Before Treatment After Treatment 
Count   
Viscosity   
Volume(ml)   
Liquification time   
Sperm concentration(millions/cumm)   
Motility(%)   
Active motile(%)   
Sluggish motile(%)   
Morphology 
Other Investigation 
TRIAL DRUG                      : VEERIYA VIRUTHI CHOORANAM 
 Dose                                      : 1Gm (bd) 
Anubanam                            : Milk 
Duration of Treatment         : 48 Days 
Pathiam (Do’s and Don’ts) 
Prognosis at the end of the Treatment. 
 
 
MEDICAL OFFICR                                   HEAD OF THE DEPARTMENT  
SIGNATURE                                                            SIGNATURE 
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DATE DAILY REPORT MEDICINE 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADVICE:  
MEDICAL OFFICER:       
                                                                                                      H.O.D/Guide 
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